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ABSTRACT
CHARACTERIZATION OF SILVER NANOPARTICLE-INFUSED TISSUE
ADHESIVE FOR OPHTHALMIC USE
by William Yee
This research examined if the infusion of silver nanoparticles into a 2-octyl
cyanoacrylate tissue adhesive alters the antibacterial effectiveness and mechanical
properties of the adhesive. Silver nanoparticle size and concentration combinations were
varied to determine the effects of these factors. Uniform distribution of the silver
nanoparticles was achieved before proceeding to testing. Antibacterial effectiveness of
the composite adhesive was determined via the Kirby-Bauer disk diffusion susceptibility
test and by CFU counting. Doping the adhesive with silver nanoparticles resulted in an
order of magnitude reduction in bacterial growth. The greatest antibacterial effect came
from imbuing 10 μg/mL of 4 nm silver nanoparticles into the tissue adhesive. Despite the
noticeable reduction of bacterial growth for the doped adhesives, the difference among
the varying silver nanoparticle size and concentration combinations was minimal.
The breaking strength of the adhesive increased when silver nanoparticles were
added. The adhesive strength of the composite adhesive attached to an incised porcine
sclera was also greater than the unaltered adhesive. The greatest breaking load and
adhesive force was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive. The
increased mechanical strength of the doped adhesive expands the possible applications of
treatment on different areas of the body.

ACKNOWLEDGEMENTS
I would like to thank God for the opportunity and provision to allow me to
complete this research. I would also like to express my gratitude to my family for the
continual support and patience during this entire process. Thanks to Dr. Benjamin
Hawkins for his guidance, insight, and effort throughout this research, especially for
exposing me to better techniques and more suitable equipment for my experiments.
Thanks to Dr. Guna Selvaduray for his feedback on how to develop my research and
experiments after I determined my research area of interest. I would like to appreciate
Dr. Jon Nunes for instilling the idea of uniformity and the perspective of how the medical
device industry thinks when developing products. I would also like to thank Neil Peters
and Jason von Linsowe for their efforts in creating parts and training me to use certain
equipment. Thanks to Intuitive Surgical for partial funding of this research. Lastly, I
would like to thank Dr. Melanie McNeil and Dr. Arthur Diaz for teaching me how to
effectively write and present my thesis research.

v

TABLE OF CONTENTS
LIST OF FIGURES ........................................................................................................... xi
LIST OF TABLES ........................................................................................................... xiv
CHAPTER ONE INTRODUCTION .................................................................................. 1
1.1

History...................................................................................................................... 1

1.1.1

History of Tissue Adhesives ............................................................................. 1

1.1.2

History of Silver Nanoparticles ........................................................................ 3

1.2

Significance.............................................................................................................. 3

1.2.1

Safety of Tissue Adhesives............................................................................... 3

1.2.2

Safety of Silver Nanoparticles .......................................................................... 4

1.2.3

Technical Importance of Tissue Adhesives ...................................................... 5

1.2.4

Technical Importance of Silver Nanoparticles ................................................. 6

1.2.5

Economic Relevance of Tissue Adhesives ....................................................... 6

1.2.6

Economic Relevance of Silver Nanoparticles .................................................. 8

1.3

Potential Areas of Research ..................................................................................... 8

1.4

Focus ........................................................................................................................ 9

CHAPTER TWO LITERATURE REVIEW .................................................................... 10
2.1

Overview ................................................................................................................ 10

2.2

Tissue Adhesives for Ophthalmic Use ................................................................... 10

vi

2.2.1

2-Octyl Cyanoacrylate .................................................................................... 10

2.2.2

Fibrin .............................................................................................................. 12

2.2.3

Hydrogels........................................................................................................ 14

2.3

Generating Silver Nanoparticles ............................................................................ 15

2.3.1

Silver Salt Precursors Used in Silver Nanoparticle Synthesis........................ 16

2.3.2

Solvents Used in Silver Nanoparticle Synthesis............................................. 17

2.3.3

Reducing Agents Used in Silver Nanoparticle Synthesis............................... 18

2.3.4

Stabilizing Agents Used in Silver Nanoparticle Synthesis............................. 19

2.4

Silver Nanoparticle Size and Concentration .......................................................... 20

2.5

Silver Nanoparticle Shape...................................................................................... 24

2.6

Infusing Silver Nanoparticles into a Polymer ........................................................ 25

2.7

Bacteria Culturing and Types of Bacteria .............................................................. 28

2.8

Antibacterial Efficacy of Silver Nanoparticle-Infused Polymers .......................... 28

2.8.1

Kirby-Bauer Disk Diffusion Susceptibility Technique .................................. 28

2.8.2

Measurement of the Colony-Forming Unit .................................................... 29

2.9

Tensile Strength ..................................................................................................... 33

2.10

Breaking Load ........................................................................................................ 35

2.11

Adhesive Force ...................................................................................................... 36

2.12

Curing Time ........................................................................................................... 40

vii

2.13

Transparency .......................................................................................................... 40

2.14

Summary ................................................................................................................ 40

CHAPTER THREE OBJECTIVE .................................................................................... 42
3.1

Objective ................................................................................................................ 42

3.2

Justification ............................................................................................................ 42

CHAPTER FOUR MATERIALS AND METHODS ....................................................... 43
4.1

Overview ................................................................................................................ 43

4.2

Materials ................................................................................................................ 43

4.3

Equipment .............................................................................................................. 44

4.4

Materials and Equipment Safety ............................................................................ 45

4.5

Experimental Methodology ................................................................................... 47

4.5.1

Experimental Matrix ....................................................................................... 47

4.5.2

Infusion of Silver Nanoparticles into the Tissue Adhesive ............................ 50

4.5.3

Silver Nanoparticle Distribution Within Adhesive ........................................ 53

4.5.4

Preparing Samples in Polyacrylamide Mold .................................................. 54

4.5.5

Antibacterial Effectiveness Testing ................................................................ 56

4.5.6

Breaking Load Testing ................................................................................... 59

4.5.7

Adhesive Force Testing .................................................................................. 60

CHAPTER FIVE RESULTS ............................................................................................ 65

viii

5.1

Silver Nanoparticle Distribution within Tissue Adhesive ..................................... 65

5.2

Antibacterial Efficacy ............................................................................................ 68

5.2.1

Kirby-Bauer Disk Diffusion Susceptibility Test ............................................ 68

5.2.2

CFU Counting ................................................................................................ 73

5.3

Breaking Load Testing ........................................................................................... 78

5.4

Adhesive Force Testing on Porcine Eyes .............................................................. 79

CHAPTER SIX DISCUSSION ........................................................................................ 83
6.1

Silver Nanoparticle Distribution within Tissue Adhesive ..................................... 83

6.2

Antibacterial Efficacy ............................................................................................ 83

6.2.1

Kirby-Bauer Disk Diffusion Susceptibility Test ............................................ 84

6.2.2

CFU Counting ................................................................................................ 85

6.3

Breaking Load Testing ........................................................................................... 88

6.4

Adhesive Force Testing on Porcine Eyes .............................................................. 89

CHAPTER SEVEN CONCLUSION................................................................................ 92
CHAPTER EIGHT FUTURE WORK.............................................................................. 94
REFERENCES ................................................................................................................. 95
APPENDIX A DISTANCES BETWEEN SILVER NANOPARTICLES ..................... 101
APPENDIX B KIRBY-BAUER DISK DIFFUSION SUSCEPTIBILITY TEST ......... 102
APPENDIX C CFU COUNTS ....................................................................................... 103

ix

APPENDIX D BREAKING LOAD TESTING ............................................................. 104
APPENDIX E ADHESIVE FORCE TESTING ............................................................. 105

x

LIST OF FIGURES
Figure 1. Experimental setup that allowed adjustment of intraocular pressure in the
anterior chamber of the eye ............................................................................... 15
Figure 2. The silver salt precursors used in scientific literature to synthesize silver
nanoparticles...................................................................................................... 16
Figure 3. The solvents used in scientific literature to synthesize silver nanoparticles ..... 17
Figure 4. The reducing agents used in scientific literature to synthesize silver
nanoparticles...................................................................................................... 19
Figure 5. The stabilizing agents used in scientific literature to synthesize silver
nanoparticles...................................................................................................... 20
Figure 6. The stirring rate affected the particle size under different silver nitrate
concentrations in 1-vinyl-2-pyrrolidinone solution at 30°C ............................. 22
Figure 7. The mean silver particle size versus various AgNO3/VP concentration
weight ratios with a stirring rate of 300 rpm at 30°C and was reduced by
ultraviolet irradiation ......................................................................................... 23
Figure 8. The size of synthesized silver nanoparticles used in scientific literature .......... 24
Figure 9. The deactivation of E. coli in relation to the interval incubation times of the
composite materials ........................................................................................... 30
Figure 10. The growth inhibition curves of E. coli in LB medium with different
silver concentrations........................................................................................ 31
Figure 11. The growth inhibition curves of S. aureus in LB medium with different
silver concentrations........................................................................................ 32
Figure 12. A stress-strain curve depicting the increased tensile strength of the
polyurethane when mixed with silver nanoparticles ....................................... 34
Figure 13. The single-arm 90° peel test ............................................................................ 37
Figure 14. The T-peel test ................................................................................................. 38
Figure 15. Flowchart illustrating the steps involved with this experiment ....................... 49

xi

Figure 16. The addition of silver nanoparticles to the tissue adhesive prior (top) and
after (bottom) vortexing and sonication .......................................................... 52
Figure 17. Machined high-density polyethylene (HDPE) solid mold used to form the
polyacrylamide mold for preparing samples for the breaking load test .......... 55
Figure 18. The polyacrylamide mold used to form the samples used for breaking load
testing .............................................................................................................. 56
Figure 19. Dog-bone shaped specimen clamped by the grips of the universal testing
machine ........................................................................................................... 60
Figure 20. The T-structure adhered to the porcine sclera prior to placing into the
vacuum eye holder .......................................................................................... 61
Figure 21. The eye holder that held the eye in the pipe adapter ....................................... 62
Figure 22. The adhesive force experimental setup ........................................................... 63
Figure 23. TEM image of the 10 nm silver nanoparticles distributed within 2-octyl
cyanoacrylate................................................................................................... 66
Figure 24. TEM image of the 4 nm silver nanoparticles to confirm the particle size ...... 67
Figure 25. TEM image of the 10 nm silver nanoparticles to confirm the particle size .... 67
Figure 26. An inhibition halo was not formed around the unaltered adhesive ................. 69
Figure 27. Magnified view of an unaltered adhesive sample at 2X magnification .......... 69
Figure 28. A composite sample displaying the presence of an inhibition halo ................ 71
Figure 29. Magnified view of a composite adhesive sample’s inhibition halo at 2X
magnification................................................................................................... 71
Figure 30. The average inhibition halo diameter for various silver nanoparticle-doped
and undoped adhesives .................................................................................... 72
Figure 31. CFU counts for each of the different tested samples ....................................... 74
Figure 32. The serial dilution of an undoped tissue adhesive ........................................... 75
Figure 33. The serial dilution of a silver nanoparticle-doped adhesive ............................ 75

xii

Figure 34. The average CFU counts of various silver nanoparticle concentration and
size combinations within the 2-octyl cyanoacrylate tissue adhesive .............. 77
Figure 35. The breaking load results of the different silver nanoparticle concentration
and size combinations within the tissue adhesive ........................................... 79
Figure 36. The broken adhesive bonds after adhesive force testing ................................. 80
Figure 37. The adhesive force results of the various doped and undoped adhesives ....... 81

xiii

LIST OF TABLES
Table 1. The surface area of the examined nanosilver shapes .......................................... 25
Table 2. The growth inhibition rates of the nanosilver shapes against S. aureus and E.
coli ...................................................................................................................... 25
Table 3. The tensile strength of each polyurethane sample containing different
concentrations of silver nanoparticles ................................................................ 33
Table 4. The mean breaking loads with the standard deviations measured in grams ....... 36
Table 5. The adhesive force for various concentrations of silver nanoparticles in the
hydrogel .............................................................................................................. 39
Table 6. The mean adhesive force for the three adhesives bonded to the three
different substrates.............................................................................................. 39
Table 7. Safety precautions for each material used in this experiment ............................ 46
Table 8. The experimental matrix containing varying levels of each factor .................... 48
Table 9. The average diameter of the inhibition halos around the various samples ......... 72
Table 10. The results of a 2-way ANOVA test from the responses generated in the
Kirby-Bauer disk diffusion susceptibility test .................................................. 73
Table 11. The average logarithmic amount of E. coli colonies for the different types
of samples ......................................................................................................... 76
Table 12. The results of a 2-way ANOVA test from the responses produced in the
CFU counting ................................................................................................... 77
Table 13. The average breaking loads for the different factor combinations ................... 78
Table 14. The results of a 2-way ANOVA test from the responses generated in the
breaking load testing ......................................................................................... 79
Table 15. The average adhesive forces for the various factor combinations .................... 81
Table 16. The results of a 2-way ANOVA test from the responses produced in the
adhesive force testing ....................................................................................... 82

xiv

CHAPTER ONE
INTRODUCTION
The repair of wounds occurring from traumatic injuries and surgical procedures
can be addressed by several wound closing methods. Some notable wound closing
methods are mechanical fasteners, such as sutures, wires, and staples [1]. As with all
medical treatments and tools, there is constant research and development of safer and
more efficient ways of treating the ailment. Thus, the development and application of
tissue adhesives became an alternative to conventional mechanical fasteners. These
tissue adhesives needed to demonstrate comparable mechanical properties as mechanical
fasteners and also prove to be an antimicrobial agent.
1.1

History

1.1.1

History of Tissue Adhesives
Tissue adhesives have been developed and applied since the 19th century [2]. At

that time, methyl-2-cyanoacrylate was the first tissue adhesive used for surgical
application. In 1909, fibrin was first applied as a hemostatic agent [3]. Fibrinogen was
then used as an adhesive in 1940 and later was developed into a biologic glue in 1944 [3].
The initial work on modern cyanoacrylates in 1949 greatly advanced the field of tissue
adhesives, which then led to the characterization of the adhesive properties of modern
cyanoacrylate in 1959 [3]. The research and progress on cyanoacrylates allowed the
adhesive to become clinically used in ophthalmic applications in 1963 and for tympanic
membrane repair in 1965 [3,4]. In addition to the use of cyanoacrylate in clinical

settings, this adhesive was used heavily during the Vietnam War [1]. Cyanoacrylate
allowed soldiers to quickly seal their wounds and ultimately aided in recovery.
In 1964, a gelatin-resorcinol-formol adhesive was created and tested and led to its
application in treating aortic dissections in 1977 [3]. This clinical application was the
first of its kind and was applied to the most important artery in the human body, which
distributes oxygenated blood to all tissue. Gelatin-resorcinol-formol was a good adhesive
that also improved hemostasis; however, this material did not promote wound healing [3].
The next major introduction to the tissue adhesive field was the United States Food and
Drug Administration’s (FDA) approval of a synthetic skin adhesive called Dermabond®
in 1998 [1]. Chemically designated as 2-octyl-cyanoacrylate, Dermabond® has been
widely accepted by surgeons and physicians for use in cosmetic surgery and in the
emergency room [1]. Dermabond® has been used to treat small lacerations and wounds
in a variety of areas on the body. The FDA approval and success of Dermabond®
spawned the development of other synthetic tissue adhesives, using different chemical
formulations, and also the discovery of further uses for natural adhesives. Despite some
“off-label” use of certain tissue adhesives, the range of applications of modern adhesives
has been expanded to almost every tissue in the body. This range of applications includes
nerve anastomosis, bone fixation, and corneal wound repair among many others [1].
Along with sealing various wounds, tissue adhesives also prevent infection. The addition
of an antimicrobial agent, such as parabens or silver nanoparticles, to tissue adhesives has
been investigated. Silver nanoparticles are a promising antimicrobial agent that has
recently been heavily examined.
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1.1.2 History of Silver Nanoparticles
For thousands of years, silver has been widely used for various functions, such as
utensils, dental alloys, and photography. Hippocrates, the father of modern medicine,
believed silver had anti-disease and healing properties and noted it as a treatment for
ulcers [5]. In 1884, the first documented medical use of silver recorded 1% silver nitrate
as an eye treatment for neonatal conjunctivitis [5]. For serious burn wounds, topically
applied silver sulfadiazine cream became the standard antibacterial treatment; its
effectiveness aids in its prevalent usage today [5]. Until antibiotics were developed,
silver compounds were major combatants of wound infection in World War I [5].
As antibiotics replaced silver compounds as the main antibacterial agent, silver
was not used as heavily in medical applications until the advent of modern science and
technology. The next major milestone for silver was the engineering of silver
nanoparticles. These nanoparticles have multiple functions and have been used in
various consumer products such as water purifiers, laundry detergents, and textiles [5].
Extensive research and development has been done to create marketable medical
products that utilize the antimicrobial properties of silver nanoparticles in applications
such as wound dressings, surgical instruments, and contraceptive devices [5].
1.2

Significance

1.2.1

Safety of Tissue Adhesives
Tissue adhesives offer many safety benefits over the use of sutures, wires, and

staples.

Mechanical fasteners are inherently invasive and pose potential damage to

tissue. Not only do sutures and the like inflict trauma on a patient’s operated tissue, but
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there is also the risk of needlestick injury to the surgeon or operating room personnel
[1,6,7]. Suture areas can also be a site for infection and inflammation, which will lead to
more complications and require additional treatment [6]. After operations, sutures and
other fasteners have a tendency to loosen and possibly break, which entails extra
treatment to fix these problems [1]. Tissue adhesives reduce or eliminate the risk of the
aforementioned safety hazards. Tissue adhesives also provide a less traumatic closure, a
reduction of blood loss by the patient, no suture removal, and less pain compared to
mechanical fasteners [1].
Despite some of the safety risks associated with mechanical fasteners, fasteners
are safer in some aspects than certain tissue adhesives. If the thrombin and fibrinogen in
fibrin glues that were obtained from human blood were not properly screened, they can
carry human viruses and other diseases [1,4]. In contrast, mechanical fasteners do not
carry the risk of transmitting diseases and viruses.
1.2.2 Safety of Silver Nanoparticles
A nanoparticle has at least one dimension that ranges between 1 and 100 nm.
Nanoparticles possess an extra-large surface area to volume ratio, which is one of the
reasons why nanoparticles display distinct physiochemical and biological properties. The
extra-large surface area to volume ratio of silver nanoparticles imbues unique
antimicrobial interactions with bacteria and viruses [5].
There is strong research evidence that supports the safety of silver nanoparticles;
however, a small fraction of research has shown that silver nanoparticles are potentially
cytotoxic. Chen and Schluesener point out that silver nanoparticles facilitate the creation
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of free radicals and reactive oxygen species (ROS) [5]. An over accumulation of ROS
can elicit an inflammatory response [5]. Long-term occupational exposure can also lead
to argyria, which is the irreversible bluish-grey pigmentation of the skin and even the
eyes [5,8]. Despite these relevant toxicological implications, most of the research data
that support silver nanoparticle cytotoxicity has been carried out by in vitro experiments.
However, cells may behave differently when they are under in vivo conditions.
1.2.3

Technical Importance of Tissue Adhesives
Tissue adhesives are highly versatile and can be used in various applications.

They are easy to use, fast to apply, do not require removal, and provide sufficient seal
quality and strength [1]. Alternatively, mechanical fasteners do pose some technical
disadvantages. Sutures, staples, and wires are not suitable for more complicated
procedures, such as sealing leaks of bodily fluids and air in blood vessels and tissues [1].
Also, there are some areas of the body that are not easily accessible for the application of
fasteners; thus, the accuracy of positioning the fasteners will be compromised.
Successful suturing involves acquired skill that only comes with talent and practice [6].
Different suturing skill levels influence the time and success of the operation.
Compared to mechanical methods, tissue adhesives are aesthetically pleasing and
the preferred choice for plastic surgeons performing cosmetic surgeries [1]. For ocular
surgeries, suturing corneas often produces asymmetrical healing which results in a
regular or an irregular astigmatism [6]. Treating this astigmatism would require more
complicated surgery or a pair of corrective spectacles.
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Mechanical fasteners have clear benefits in certain applications in the body. For
deep tissue wounds and lacerations, the use of deep support sutures promote the healing
process and provide more than adequate mechanical strength to join two tissues together
[1]. Some wounds and lacerations are large and wide, requiring fasteners instead of
tissue adhesives because of the possibility that the wound reopens and takes a longer time
to heal. Mechanical fasteners can also complement tissue adhesives in appropriate
situations by assisting with the healing process. In the end, the suitable treatment is
dependent on the type of wound and the doctor’s preference of treatment.
1.2.4

Technical Importance of Silver Nanoparticles
When compared to their antibiotic counterparts, silver nanoparticles are highly

effective against organisms that have developed a resistance to multiple drugs [8].
Additionally, these nanoparticles have a multilevel antibacterial effect on cells, which
allows the silver to interact with organisms and reduce their chance of developing
resistance to treatment [8]. Silver nanoparticles are bactericidal because they bind to the
bacteria’s cell wall, alter their cytoplasmic DNA and proteins, and modify the enzymes
involved in essential cellular processes [8]. Furthermore, latest research has found that
silver nanoparticles possess anti-inflammatory properties that might be due to the
reduction of cytokine release and the decrease infiltration of mast cells and lymphocytes
[8].
1.2.5

Economic Relevance of Tissue Adhesives
There are more than 12 million procedures done annually throughout the world

that require the use of nylon sutures to close ocular wounds alone [6]. Since the eyes are
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commonly operated on, it is safe to say that there are many more millions of procedures
that require wound closure. Non-dissolvable mechanical fasteners require removal by the
doctor. Trauma occurs and the opportunity for infection is present every time sutures are
removed [6]. The need for patients to come back to the doctors to have mechanical
fasteners removed and the chance that further complications might arise requiring
subsequent treatments is highly undesirable and ultimately uneconomical. Visiting the
doctor for follow-up medical attention will incur additional costs to patients and
potentially the government via Medicare or Medicaid. Alternatively, tissue adhesives
eliminate the need for mechanical fastener removal and the possibility of additional
trauma and infection. From a doctor’s perspective, adhesives will reduce the surgery
time, allowing the doctor to operate on more patients and ultimately earn more money.
The large volume of procedures that require wound closure presents a viable
market for tissue adhesives. While mechanical fasteners remain the most common
method for wound closure, recent advances are making tissue adhesives a viable
alternative and potential replacement wound closure technique. Hence, there is a
growing amount of research and development for the application of various natural,
synthetic, semisynthetic, and biomimetic tissue adhesives [1]. Despite the fact that some
adhesives are more expensive than typical sutures, the favorable properties and the
development of more commercial adhesives establishes tissue adhesives as an
economical option for wound care management.
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1.2.6

Economic Relevance of Silver Nanoparticles
The commercial nanotechnology industry is expected to reach $3 trillion by 2015

[9]. Because nanomaterials have been incorporated in many sectors of society, there is
no doubt that there is a massive economic impact. Silver nanoparticles are the most
commercialized nanomaterial in the medical field [5]. Current and future research of
silver nanoparticles will further expand the market for medical products containing the
effective antimicrobial property of the nanoparticle.
1.3

Potential Areas of Research
Injury can occur at every part of the body, which necessitates doctors to care for

them with different treatments and tools. The past century featured many advances in the
field of wound care management, as evidenced by the various fields utilizing tissue
adhesives. Some of these fields include hematology, gynecology, neurology, cardiology,
urology, dentistry, dermatology, and ophthalmology [1]. Even though all these fields
vary in the type of procedures performed, repairing wounds requires a tissue adhesive
that possesses ideal properties.
First, the tissue adhesive needs to hold together two sides of tissue until the body
can properly heal the wound [1]. Second, the adhesive should be able to polymerize in a
moist environment within a reasonable curing time [1,2]. Third, the adhesive must be
steadily metabolized by the surrounding tissue without generating an inflammatory
response or be a site for infection [1,6]. Lastly, the adhesive should not deform the tissue
and cause discomfort to the patient postoperatively [1,2]. All of these features are what
all tissue adhesives should essentially share in common.
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Silver nanoparticles must have low systemic toxicity and be effective as a
bactericide. There has been minimal research on the infusion of silver nanoparticles into
a tissue adhesive. To the author’s knowledge, there has been no research on the
application of silver nanoparticle-infused tissue adhesives for ophthalmic use. The eyes
are important organs of the body and are subjected to various procedures. As a result, the
eyes have the potential to be a site for infection and inflammation.
1.4

Focus
This research focused on the infusion of silver nanoparticles in tissue adhesives

for ophthalmic use. The effectiveness of the antimicrobial property of silver
nanoparticles mixed with the adhesive was studied. Furthermore, the mixture adhesive
was examined to determine if the silver nanoparticles alter the mechanical properties of
the adhesive.
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CHAPTER TWO
LITERATURE REVIEW
2.1

Overview
Tissue adhesives offer many benefits in repairing traumatic and surgical wounds.

To be effective, tissue adhesives need to be nontoxic, have a rapid curing time, and
possess favorable mechanical properties. The mechanical properties of tissue adhesives
changes when silver nanoparticles are infused into the adhesive. Furthermore, the
antibacterial efficacy is affected when silver nanoparticles are infused into a polymer.
This chapter discusses the previous research performed that evaluates the mechanical and
antibacterial properties of the infusion of silver nanoparticles into a polymer. Despite the
research conducted in the addition of silver nanoparticles to a polymer, there are no
studies on the infusion of silver nanoparticles into a tissue adhesive for ophthalmic use.
This literature review investigates the areas needed to develop this tissue adhesive for the
use in the eye.
2.2

Tissue Adhesives for Ophthalmic Use

2.2.1

2-Octyl Cyanoacrylate
Multiple types of tissue adhesives have been tested for various ophthalmic

wounds and conditions. A common adhesive is 2-octyl cyanoacrylate. Ritterband et al.
used this adhesive to seal clear cataract wounds. Due to the influx of surface bacteria
present in extraocular fluid before wound epithelialization, a 3.0 mm clear corneal
incision is a possible site of infection and inflammation [10]. Ritterband et al. studied the
effectiveness of 2-octyl cyanoacrylate (Liquid Bandage™, Johnson & Johnson) in sealing
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a clear corneal incision by testing the influx of India ink with varying intraocular
pressures and manual wound manipulations. India ink was used because the opaque fluid
particle size is comparable to the size of bacteria [10]. The dynamic flow of fluid at
varying intraocular pressures and wound manipulations attempts to simulate the
unpredictability of the eye environment.
This study by Ritterband and his group had two phases to prove the sealing
efficacy of the adhesive. In the first phase, the researchers created corneal incisions in
seven human cadaver eyes to test the influx of India ink by adjusting the intraocular
pressure from 4 mmHg to 22 mmHg and manipulating the wound by manually applying
70 mmHg of pressure to the wound [10]. The second phase consisted of the same
experiment as phase one, but this time the corneal incisions were sealed with 2-octyl
cyanoacrylate. For phase one, one eye demonstrated the ingress of fluid when the
intraocular pressure was less than 5 mmHg, while India ink leaked into the anterior
chamber of the other eyes when more than 70 mmHg of manual pressure was applied on
the incision [10]. In contrast, all of the human eyes with the 2-octyl cyanoacrylate sealed
corneal incisions did not experience any influx of India ink when the same tests were
applied.
Meskin et al. confirmed the sealing efficacy of the same 2-octyl cyanoacrylate
tissue adhesive used in the Ritterband et al. study. Instead of using human cadaver eyes,
the Meskin et al. study was assessed in vivo in 51 eyes of 51 cataract surgery patients.
After the cataract surgery and before the application of the adhesive, all incisions were
hydrated with a balanced saline solution and were examined for leakage by applying
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gentle pressure to the wound with a cellulose sponge. Out of the 51 eyes, seven of the
eyes displayed leakage [11]. There was no leakage present in all 51 eyes when the
adhesive was applied.
In other research, Duffy et al. created and tested a scaffold-enhanced 2-octyl
cyanoacrylate adhesive composite that was intended for correcting strabismus.
Strabismus is the misalignment of the eyes due to the lack of synchronization between the
extraocular muscles, which results in the inability of both eyes to focus on the same point
[12]. Duffy et al. evaluated the breaking loads of extraocular muscles to ocular tissues or
other extraocular muscles using the scaffold-enhanced adhesive. A scaffold was added to
the 2-octyl cyanoacrylate adhesive because the scaffold increased the breaking load of the
adhesive [7]. The scaffolds used were made out of either poly(L-lactic-co-glycolic acid)
(PLGA) or porcine small intestine submucosa. The 2-octyl cyanoacrylate used was
Dermabond®. As a reference, Duffy and his group analyzed the breaking loads of an
unoperated eye and its extraocular muscles. Next was the testing of the breaking loads
between the ocular tissues and extraocular muscles with 2-octyl cyanoacrylate alone and
also with the scaffold-enhanced composite adhesive. The breaking load was found to be
greatest with the composite adhesive, while the breaking load of 2-ocytl cyanoacrylate
was the next highest and the unoperated eye was the lowest [7]. Further details of this
study are discussed in the Section 2.10.
2.2.2

Fibrin
Fibrin is another common tissue adhesive for ophthalmic use. Banitt et al.

compared the sealing ability of a fibrin adhesive (Tisseel®, Baxter Healthcare
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Corporation), n-butyl-2-cyanoacrylate (Histoacryl®, TissueSeal) adhesive, and 10-0
nylon sutures on clear corneal incisions. The research focused on the relation between
incision size and the intraocular pressure when leakage occurred after an adhesive or
suture was applied. Using porcine eyes, Banitt et al. gradually increased the intraocular
pressure from 20 mmHg to 700 mmHg. The results of the study showed that regardless
of the incision size, the n-butyl-2-cyanoacrylate adhesive was far superior in sealing clear
corneal incisions because of the high pressures the adhesive can withstand before liquid
seeps in [13]. Fibrin was generally the second best adhesive when sealing clear corneal
incisions; however, as the incision size increased, the sealed corneas that used 10-0 nylon
sutures were able to withstand a similar intraocular pressure as their fibrin counterparts.
The intraocular pressure that the n-butyl-2-cyanoacrylate adhesive can tolerate before the
corneal incision leaked was about two to three times more than the intraocular pressure
that the fibrin adhesive or 10-0 nylon sutures can handle.
Fibrin is also used as a tissue adhesive to secure a lamellar graft and to attach
amniotic tissue to a bare scleral wound. Kaufman et al. used a fibrin adhesive (Tisseel®
VH Fibrin Sealant, Baxter Healthcare Corporation) to fasten a lamellar graft and found
that all five of the patients’ lamellar grafts were healed and transparent. In addition, the
amniotic tissue was affixed securely onto the bare sclera of a patient. Based on the
successful results of the study, Kaufman et al. concluded that the adhesive should be
effective in sealing LASIK corneal flaps, conjunctival grafts, and clear corneal incisions
[4]. However, in agreement with Banitt et al., Kaufman and his colleagues noted the
lengthy 20 min preparation time of mixing the fibrin ingredients and the high cost of the
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adhesive ($121 for 2 mL) compared to sutures ($15) [4,13]. Also, if not properly
screened, fibrin adhesives obtained from human blood can carry viruses and other
diseases [1,4].
2.2.3 Hydrogels
Hovanesian tested the sealing effectiveness of a polyethylene glycol hydrogel
adhesive (I-ZIP® Ocular Bandage, I-Therapeutix). Clear corneal incisions were made on
24 human cadaver eyes and were tested for India ink leakage under low pressure
conditions and with external wound manipulations. Twelve eyes were treated with the
hydrogel adhesive and reported no fluid ingress when the intraocular pressure was at 33
mmHg, which is similar to the intraocular pressure of an incision during cataract surgery
[14]. Furthermore, no fluid leakage was observed when there was external manipulation
of the incision. The other twelve eyes were set apart as controls. Nine of the control eyes
experienced fluid influx with varying intraocular pressures, while eleven of the control
eyes leaked India ink with external manipulation of the wound [14].
Strehin et al. evaluated the sealing ability of a chondroitin sulfate-polyethylene
glycol adhesive. To test the sealing effectiveness of the synthesized adhesive, the
researchers measured the intraocular pressure when the excised porcine eyes began to
leak. The experiment was set up to allow the variation of intraocular pressure with a
pressure sensor and a 20-gauge needle connected to a syringe pump that was inserted into
the anterior chamber of the eye [15]. Once the eye was in equilibrium, Strehin and his
group increased the pumping of fluid into the eye to ensure a non-self-sealing incision
that aided in demonstrating the functionality of the adhesive. This experimental setup is
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exhibited in Figure 1. Two out of the three adhesive treated eyes maintained wound
sealing integrity at intraocular pressures greater than 200 mmHg. One eye experienced
leakage at 200 mmHg.

Figure 1. Experimental setup that allowed adjustment of intraocular pressure in the
anterior chamber of the eye. The intraocular pressure was increased until fluid leaked
through the incision [15]. (Reprinted from J. Cataract Refractive Surg., 35, I. Strehin,
W.M. Ambrose, O. Schein, A. Salahuddin and J. Elisseeff, Synthesis and
characterization of a chondroitin sulfate-polyethylene glycol corneal adhesive, 567-576,
2009, with permission from Elsevier)
2.3

Generating Silver Nanoparticles
Silver nanoparticles are synthesized by either the top-down or bottom-up

techniques [16]. The top-down approach mechanically reduces bulk silver to the
nanoscale size via laser ablation and lithography [17]. Conversely, the bottom-up
approach is the dissolution of silver salt into a solvent [16]. The addition of a reducing
agent and stabilizing agent precipitates formation of silver nanoparticles [16]. The
bottom-up technique is the preferred and predominant method to synthesize silver
nanoparticles primarily because the mechanical reduction of the top-down technique
produces surface imperfections, which impacts the applicability of the silver
nanoparticles [16,18].
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2.3.1

Silver Salt Precursors Used in Silver Nanoparticle Synthesis
In the bottom-up method, silver salt precursors are dissolved in a solvent to

produce ionic silver as part of the synthesis of silver nanoparticles [16]. When compared
to other silver salt precursors, silver nitrate (AgNO3) is the predominant silver salt
precursor used in research due to its chemical stability and low cost [16,19]. In a
scientific literature review conducted by Tolaymat et al., 200 pertinent articles referenced
the statistics involved with the synthesis of silver nanoparticles. The percentage of
certain silver salt precursors used in the scientific literature review in relation to other
salts is portrayed in Figure 2.

Figure 2. The silver salt precursors used in scientific literature to synthesize silver
nanoparticles. Silver nitrate accounted for 83% of the silver salt precursors in the review
[16]. (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A.
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental
perspective of manufactured silver nanoparticle in syntheses and applications: A
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006,
2010, with permission from Elsevier)
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2.3.2

Solvents Used in Silver Nanoparticle Synthesis
In the bottom-up method, organic and inorganic solvents are used to dissolve the

silver salt precursors as part of the silver nanoparticle synthesis process [16]. Organic
solvents are heavily used for the production of high particle concentrations with a
predefined shape and size [20,21]. Due to the low cost and availability of water, it is the
prime solvent used in the synthesis of silver nanoparticles [16]. Water is used to generate
stable and mobile silver nanoparticles in an aqueous environment [16]. The number of
researchers using water as a solvent in comparison to other solvents is shown in Figure 3.

Figure 3. The solvents used in scientific literature to synthesize silver nanoparticles.
Water accounted for about 60% of the solvents in the review. The diagonal-shaded bars
depict the solvents used for the synthesis of silver nanoparticles for certain applications
[16]. (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A.
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental
perspective of manufactured silver nanoparticle in syntheses and applications: A
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006,
2010, with permission from Elsevier)

17

2.3.3

Reducing Agents Used in Silver Nanoparticle Synthesis
The use of a reducing agent is necessary for the bottom-up approach of

synthesizing silver nanoparticles. Reducing agents offer free electrons to reduce the
silver ions that will eventually form the nanoparticles [16]. These agents can be a
chemical or biological agent, plant extract, or an irradiation method [16]. Sodium
borohydride (NaBH4) and sodium citrate are the prevalent reducing agents used to form
silver nanoparticles, which is shown in Figure 4 of the Tolaymat et al. study. Sodium
borohydride is a strong reducing agent that typically generates a narrow range of small,
uniform particles [16]. To form larger particles, a weaker reducing agent is used such as
ascorbic acid [22].
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Figure 4. The reducing agents used in scientific literature to synthesize silver
nanoparticles. Sodium borohydride (NaBH4) and sodium citrate accounted for about
33% of the reducing agents in the review. The diagonal-shaded bars depict the reducing
agents used for the synthesis of silver nanoparticles for certain applications. The “other”
category was composed of reducing agents that were rarely used in the literature review
[16]. (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A.
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental
perspective of manufactured silver nanoparticle in syntheses and applications: A
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006,
2010, with permission from Elsevier)
2.3.4

Stabilizing Agents Used in Silver Nanoparticle Synthesis
In the bottom-up approach, stabilizing agents are used to control the size of the

nanoparticle and to prevent nanoparticle agglomeration [16]. According to the research
of Olenin et al., the aggregation of nanoparticles is due to the high thermodynamic
instability and extra surface energy on the particle surface [23]. Stabilizing agents can be
surfactants or polymers containing functional groups [16,23]. The concentration of a
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stabilizing agent also determines the reactivity, solubility, stability, shape, and size of the
nanoparticle [24]. The different types of stabilizing agents are illustrated in Figure 5.

Figure 5. The stabilizing agents used in scientific literature to synthesize silver
nanoparticles. Sodium citrate accounted for about 27% of the stabilizing agents in the
review. The diagonal-shaded bars depict the stabilizing agents used for the synthesis of
silver nanoparticles for certain applications. The “other” category was composed of
stabilizing agents rarely used in the literature review [16]. (Reprinted from Sci. Total
Environ., 408, T.M. Tolaymat, A.M. El Badawy, A. Genaidy, K.G. Scheckel, T.P.
Luxton and M. Suidan, An evidence-based environmental perspective of manufactured
silver nanoparticle in syntheses and applications: A systematic review and critical
appraisal of peer-reviewed scientific papers, 999-1006, 2010, with permission from
Elsevier)
2.4

Silver Nanoparticle Size and Concentration
In a study performed by Lee and Tsao, they examined the factors that effected

silver nanoparticle diameter size. A particle size analyzer was used to measure the silver
nanoparticle size. The study used 100 mL of 100 ppm silver nitrate solution as the silver
salt precursor and mixed it with 1 g of 1-vinyl-2-pyrrolidinone in 100 mL of water at
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room temperature for 12 h [25]. The researchers found that the silver nanoparticle size
increased as the concentration of the silver nitrate solution in 1-vinyl-2-pyrrolidinone
mixture increased [25]. Lee and Tsao recognized that the increase of particle size was the
result of an agglomeration of silver nanoparticles due to the lack of a stabilizing agent
when the concentration of the silver aqueous mixture increased [25]. This finding
supports the research of Olenin et al., which also found that the aggregation of particles
was prevented by the addition of a stabilizing agent.
Additionally, the results demonstrated that the silver particle size was notably
affected by the stirring rate and the silver nitrate/1-vinyl-2-pyrrolidinone (AgNO3/VP)
mixture concentration ratio [25]. Figure 6 shows that a higher stirring rate means a
smaller particle size; however, the increased concentration of silver nitrate in the
AgNO3/VP mixture also means an increase of particle size, regardless of the higher
stirring rate. The 300 nm particle size with the higher stirring rate depicted in Figure 6
cannot be considered a nanoparticle because a nanoparticle is between 1 and 100 nm in
size [5]. Nevertheless, the study does reveal that a higher stirring rate translates to the
generation of a smaller particle.
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Figure 6. The stirring rate affected the particle size under different silver nitrate
concentrations in 1-vinyl-2-pyrrolidinone solution at 30°C [25]. (Reprinted from J.
Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on the
various properties of nanocomposite hydrogels by in situ polymerization, 89-97, 2010,
with permission from Springer Science and Business Media)
The AgNO3/VP mixture weight ratio was also an important factor that was
considered to produce appropriate sized silver nanoparticles. Figure 7 shows that silver
particle size was affected by different silver nitrate concentrations under varying
AgNO3/VP weight ratios. With a lower AgNO3/VP weight ratio, the silver particle size
decreased to become equal or less than 100 nm, which is in the size range of a
nanoparticle [5,25]. Lee and Tsao concluded that when the AgNO3/VP weight ratio was
lowered to 1/10, the extra 1-vinyl-2-pyrrolidinone chelated the dispersible silver ions to
form the smallest silver particle diameter size at 72 nm [25].

22

Figure 7. The mean silver particle size versus various AgNO3/VP concentration weight
ratios with a stirring rate of 300 rpm at 30°C and was reduced by ultraviolet irradiation.
When the AgNO3/VP weight ratio was lowered to 1/10, the smallest particle size can be
formed to be 72 nm [25]. (Reprinted from J. Mater. Sci., 45, W-F. Lee and K-T. Tsao,
Effect of silver nanoparticles content on the various properties of nanocomposite
hydrogels by in situ polymerization, 89-97, 2010, with permission from Springer Science
and Business Media)
The review conducted by Tolaymat’s group concluded that researchers preferred
to use smaller sized particles, especially between 0 and 10 nm [16]. Different
nanoparticle sizes were chosen based on what was more suitable for the application. In
Figure 8, the nanoparticle size of 0-10 nm is shown to be used in 45% of general
applications, which is almost double the percentage of the next most commonly used
particle size of 11-20 nm [16].
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Figure 8. The size of synthesized silver nanoparticles used in scientific literature. The
range of 0 to 10 nm accounted for about 45% of the nanoparticle sizes in the review. The
diagonal-shaded bars depict the silver nanoparticle sizes used in specific applications
[16]. (Reprinted from Sci. Total Environ., 408, T.M. Tolaymat, A.M. El Badawy, A.
Genaidy, K.G. Scheckel, T.P. Luxton and M. Suidan, An evidence-based environmental
perspective of manufactured silver nanoparticle in syntheses and applications: A
systematic review and critical appraisal of peer-reviewed scientific papers, 999-1006,
2010, with permission from Elsevier)
2.5

Silver Nanoparticle Shape
Silver nanoparticles are formed into many different shapes such as plates, rods,

spheres, triangles, and hexagons [16,26]. Sadeghi et al. studied the antibacterial
effectiveness of a few of these various shapes. They used N-N’-dimethyl formamide to
reduce silver nitrate and poly(N-vinyl-2-pyrrolidone) to stabilize the mixture to produce
uniform, non-agglomerated particles [26,27]. The results showed that the antibacterial
efficacy of silver nanoparticles was highly dependent on the amount of surface area of the
particle that the bacteria can interact with [26]. Table 1 displays the surface area of the
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nanosilver shapes examined by Sadeghi’s group, which includes hexagonal nanoparticles,
nanorods, and nanoplates. Table 2 presents the growth inhibition rates of the nanosilver
shapes against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). This
table supports the study’s conclusion that a larger nanoparticle surface area increases the
antibacterial efficacy.
Table 1. The surface area of the examined nanosilver shapes [26]. (Reprinted from
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad,
A. Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity
on the nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with
permission from Elsevier)
Nanosilver Shapes
Silver Hexagonal Nanoparticles
Silver Nanorods
Silver Nanoplates

2

Surface Area (m /g)
17.8
38.8
121.1

Table 2. The growth inhibition rates of the nanosilver shapes against S. aureus and E.
coli. Note that the growth inhibition rates of all nanosilver shapes were high, which
means that regardless of the shape chosen, the antibacterial property of nanosilver
was effective [26]. (Reprinted from Adv. Powder Technol., 23, B. Sadeghi, F.S.
Garmaroudi, M. Hashemi, H.R. Nezhad, A. Nasrollahi, S. Ardalan and S. Ardalan,
Comparison of the anti-bacterial activity on the nanosilver shapes: Nanoparticles,
nanorods and nanoplates, 22-26, 2012, with permission from Elsevier)

Sample (10 ppm)
Silver Hexagonal Nanoparticles
Silver Nanorods
Silver Nanoplates
2.6

Growth Inhibition Rate (%)
S. aureus
E. coli
95.5
92.5
97.3
93.4
98.5
94.2

Infusing Silver Nanoparticles into a Polymer
The incorporation of silver nanoparticles into a polymer can be done by a few

approaches, such as in situ, ex situ, melt processing, and sonication [25,28,29]. The ex
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situ approach is when the silver nanoparticles are generated via soft-chemistry routes and
then spread throughout a polymer matrix [25]. The in situ approach is when the silver
nanoparticles are produced inside a polymer matrix via decomposition or chemical
reduction of the silver salt precursor dissolved into the polymer [25]. The melt
processing method is when the silver nanoparticles and polymer are mixed together at
high temperatures while being spun at a constant speed [30]. For the melting process,
Radheshkumar and Münstedt produced the melted compound with an internal mixer at
230°C while rotating at 60 rpm for 7 min [30]. Sonication uses ultrasonic energy to
evenly disperse nanoparticles within a liquid or polymer [29]. The two methods of
sonication are direct and indirect sonication. Direct sonication is the production of
ultrasonic waves in the polymer by immersing an ultrasonic probe within the polymer
suspension [29]. Indirect sonication is the propagation of ultrasonic waves through a
liquid bath surrounding the nanoparticle-doped polymer sample container [29].
The in situ method is a commonly used technique in the scientific literature to
generate a polymer containing silver nanoparticles. Lee and Tsao applied this method to
produce a silver nanoparticle-infused hydrogel that was used as a bioadhesive for hard
and soft tissue applications [25]. The first step of creating the silver nanoparticle-infused
hydrogel was the addition of a 1-vinyl-2-pyrrolidinone/silver ion precursor solution into a
monomer solution containing 1 mol% of ethylene glycol dimethacrylate (EGDMA) and 1
mol% of 2,2-diethoxyacetophenone (DEAP) [25]. EGDMA was a crosslinker and DEAP
was a photoinitiator [25]. Lastly, the mixture was polymerized and reduced
simultaneously by exposing the solution to 600 W of ultraviolet radiation for 2 h [25].
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Deka et al. used an in situ polymerization technique to create a silver
nanoparticle-infused polyurethane [31]. A silver nitrate solution was reduced by N,N’dimethylformamide (DMF) and was added to a hyperbranched polyurethane matrix at
room temperature [31]. Subsequently, the mixture was vigorously stirred for 2.5 h [31].
The researchers found that the nature of the atmosphere has no effect on the formation of
the silver nanoparticle-infused polyurethane [31]. Uniform distribution of the silver
nanoparticles in the polyurethane was confirmed via transmission electron microscopy
(TEM).
Zhou et al. used the in situ approach to synthesize a silver nanoparticle-doped
gelatin and carboxymethyl chitosan (CM-chitosan) hydrogel [32]. These generated
hydrogels proved to be stable and have homogenous distribution of the silver
nanoparticles in the polymer matrix [32]. The first step in preparing the infused
hydrogels was dissolving silver nitrate powder into deionized water. Next, a 10 wt%
total concentration of a 2:3 weight ratio of gelatin and CM-chitosan powders were mixed
into the silver solution at 50°C with an ARE-310 hybrid mixer for 20 min to produce a
homogenous polymer solution [32]. Zhou et al. used 30 kGy of gamma radiation at
ambient temperature located in a 60Co facility as a crosslinker and reducing agent [32].
Lin et al. examined the dispersion of silver nanoparticles with sonication. They
observed the dispersion of the nanoparticles with a field emission scanning electron
microscope (FE-SEM). The ultrasonic energy delivered at various power intensities was
sufficient in dispersing the nanoparticles. Greater ultrasonic power delivered to
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agglomerated silver nanoparticles provided better dispersion [33]. However, greater
ultrasonic energy also signified that more heat was imparted to the sample.
2.7

Bacteria Culturing and Types of Bacteria
Two of the most common bacteria used in determining the antibacterial properties

of silver nanoparticles are S. aureus and E. coli [26,28,31]. Despite multiple methods of
culturing bacteria, there are some commonalities in the bacterial culturing process. Zhou
et al. cultivated their E. coli bacterial culture at 37°C in a sterilized Luria-Bertani (LB)
broth [32]. The mixture was placed into a rotary shaker and shaken at 150 rpm for 16 h
[32]. Lee and Tsao also used a similar preparation method for their bacterial culture. E.
coli was preserved on LB agar, which was composed of a LB medium and 15 g/L of agar
[25]. The bacterial cells were added to 100 mL of LB medium and were placed into a
37°C incubator to be shaken at 170 rpm for 12 to 16 h [25]. Likewise, Deka et al.
incubated S. aureus and E. coli bacteria at 37°C for 24 h by adding it to a Mueller Hinton
broth [31].
2.8

Antibacterial Efficacy of Silver Nanoparticle-Infused Polymers

2.8.1 Kirby-Bauer Disk Diffusion Susceptibility Technique
Zhou et al. used the Kirby-Bauer disk diffusion susceptibility test to assess the
antibacterial performance of the silver nanoparticle-infused hydrogel [32]. They first
dispensed 50 μL of bacteria medium containing a concentration of 106 colony-forming
units per milliliter (CFU/mL) of E. coli onto an agar plate. A disk-shaped sample of the
silver nanoparticle-infused hydrogel was then placed on the agar plate and incubated at
37°C for 12 h [32]. After the incubation period, the diameter of the bacterial growth
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inhibition halo around each composite sample was measured to determine the
antibacterial efficacy of the composite [32]. A larger inhibition halo diameter signified
the bacteria having a larger susceptibility to the antibacterial composite.
Sadeghi et al. also used the Kirby-Bauer technique by placing nanosilver-filled
disks onto separate S. aureus and E. coli-filled agar plates and incubated the sample
mediums for 24 h at 37°C [26]. During the incubation period, the samples were supposed
to absorb water from the agar plate while the antibacterial silver diffused into the
surrounding agar [26,34]. The diameters of the inhibition halos were measured to detect
the effectiveness of the antibacterial samples.
2.8.2

Measurement of the Colony-Forming Unit
Lee and Tsao assessed the antibacterial activity of their silver nanoparticle-

infused hydrogel by adding the bacterial culture to the composite samples in sterile water
and incubated it in a 37°C shaker [25]. The samples were removed in 20 min intervals
between 20 and 120 min [25]. This solution was diluted between 103 and 105 fold with a
0.85 % saline solution and was mixed with LB broth [25]. After gentle shaking of the
mixture, the contents remained untouched until solidified. Following two days of
incubation at 37°C, the developed colonies were counted to determine their viability in
the antibacterial environment [25]. The viability was represented by the log of the
colony-forming unit per milliliter [25]. Figure 9 illustrates the deactivation of E. coli by
comparing the change in viability during the interval incubation times. The deactivation
of the bacteria was greatest when the silver nanoparticle concentration was the highest
[25].
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Figure 9. The deactivation of E. coli in relation to the interval incubation times of the
composite materials. APEAg is the sample code prefix, while the subsequent sample
numbers denote the multiples of 55.6 ppm silver nanoparticles in the sample. The
viability corresponds to the log of the colony-forming unit per milliliter [25]. (Reprinted
from J. Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on
the various properties of nanocomposite hydrogels by in situ polymerization, 89-97,
2010, with permission from Springer Science and Business Media)
Sadeghi et al. also measured the colony-forming unit in their study. A mixture of
nanosilver and 1.5 x 105 colony-forming units of S. aureus and E. coli were cultured at
37°C in a shaking incubator for 12 h [26]. This mixture was then seeded onto a LB agar
plate and incubated for 24 h at 37°C [26]. After the incubation time, the colony-forming
units were counted. The counted number was used in Equation 1 to calculate the
antibacterial efficacy of the nanosilver samples.
ABE (%) = [(Vc – Vt) / Vc] * 100

30

Equation 1

Vc and Vt symbolize the number of viable bacterial colonies of the silver nitrate blank
control and nanosilver samples, respectively [26]. Figure 10 and Figure 11 shows the
growth inhibition curves of E. coli and S. aureus in LB medium with different silver
concentrations, respectively.

Figure 10. The growth inhibition curves of E. coli in LB medium with different silver
concentrations. Note the effectiveness of the nanosilver samples in decreasing the
number of bacterial colonies over time. Ag-NPs, Ag-NRds, and Ag-NPls denote silver
nanoparticles, silver nanorods, and silver nanoplates, respectively [26]. (Reprinted from
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad, A.
Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity on the
nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with
permission from Elsevier)
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Figure 11. The growth inhibition curves of S. aureus in LB medium with different silver
concentrations. Note the effectiveness of the nanosilver samples in decreasing the
number of bacterial colonies over time. Ag-NPs, Ag-NRds, and Ag-NPls denote silver
nanoparticles, silver nanorods, and silver nanoplates, respectively [26]. (Reprinted from
Adv. Powder Technol., 23, B. Sadeghi, F.S. Garmaroudi, M. Hashemi, H.R. Nezhad, A.
Nasrollahi, S. Ardalan and S. Ardalan, Comparison of the anti-bacterial activity on the
nanosilver shapes: Nanoparticles, nanorods and nanoplates, 22-26, 2012, with
permission from Elsevier)
Liu et al. embedded three average sizes of silver nanoparticles within
polyurethane. The average sizes were 3, 6, and 25 nm. They performed a CFU count test
and found that a smaller average silver nanoparticle size demonstrated the greatest
antibacterial effect [35]. As the nanoparticle size increased, the antibacterial
effectiveness decreased. The smaller silver nanoparticles were characterized by a larger
surface area to volume ratio to interact with the bacteria and impart its bactericidal
property [35]. Liu et al. also found that increasing the silver nanoparticle concentration
increased the antibacterial efficacy of the polyurethane.
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2.9

Tensile Strength
The tensile strength of a material is typically tested by a universal testing machine

[7,31]. Deka et al. created polymers that contained 1, 2.5, and 5 wt% of silver
nanoparticles to see if the silver nanoparticles influenced the tensile strength of the
polyurethane [31]. The group used a universal testing machine that had a 10 kN load cell
and a 50 mm/min crosshead speed to test the tensile strength [31]. They found that the
increased concentration of the silver nanoparticles increased the tensile strength of the
composite material. The values obtained from the universal testing machine are
displayed in Table 3. In Figure 12, a stress-strain curve depicts the improved tensile
strength of the polyurethane when mixed with silver nanoparticles. Deka et al. suggested
that the improved tensile strength was due to the increased interactions of the silver
nanoparticles with the hard segment of the polyurethane matrix [31].
Table 3. The tensile strength of each polyurethane sample containing different
concentrations of silver nanoparticles. Tensile strengths were measured and
expressed as the mean ± standard deviation. HBPU stands for hyperbranched
polyurethane. HBPUAg + number stands for a hyperbranched polyurethane
containing a weight percent of silver nanoparticles. LPU stands for linear
polyurethane. LPUAg + number stands for a linear polyurethane containing a weight
percent of silver nanoparticles [31]. (Reprinted from Polym. Degrad. Stab., 95, H.
Deka, N. Karak, R.D. Kalita and A.K. Buragohain, Bio-based thermostable,
biodegradable and biocompatible hyperbranched polyurethane/Ag nanocomposites
with antimicrobial activity, 1509-1517, 2010, with permission from Elsevier)

HBPU

HBPU Ag1 HBPU Ag2.5 HBPU Ag5 LPU

Tensile
Strength
(MPa) 6.80 ± 1.2 8.13 ± 1.4

9.42 ± 1.1
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LPU Ag2.5

11.51 ± 1.5 5.31 ± 0.95 9.60 ± 1.1

Figure 12. A stress-strain curve depicting the increased tensile strength of the
polyurethane when mixed with silver nanoparticles [31]. (Reprinted from Polym.
Degrad. Stab., 95, H. Deka, N. Karak, R.D. Kalita and A.K. Buragohain, Bio-based
thermostable, biodegradable and biocompatible hyperbranched polyurethane/Ag
nanocomposites with antimicrobial activity, 1509-1517, 2010, with permission from
Elsevier)
Liu et al. measured the tensile strength of their silver nanoparticle-embedded
polyurethane. Their specimens were cut to a length and width of 20 mm by 1 mm and
tested on a universal testing machine. The specimens were pulled at 1 mm/min until
fracturing. The tensile strength noticeably increased for the polyurethane prepared
without a crosslinker than the polyurethane prepared with a crosslinker [35]. The
polyurethane prepared without a crosslinker had an average tensile strength of 10.5 MPa
[35]. The polyurethane prepared with a crosslinker had an average tensile strength of
20.5 MPa [35].
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2.10

Breaking Load
Kull et al. evaluated the breaking strength of a n-butyl-2-cyanoacrylate adhesive

called Glubran2 and a fibrin glue called Tissucol. A dog-bone shaped silicone rubber
mold mounted on a Teflon plate was created to prepare the dog-bone shaped specimen
used for testing. An activator was sprayed on the Teflon plate to trigger polymerization
of the adhesive. The adhesive was dispensed into the dog-bone shaped mold and allowed
to polymerize for 24 h at 25°C room temperature. The samples were attached to a
material testing machine equipped with a 100 N load cell and pulled until breakage
occurred at the reduced section of the dog-bone shaped specimen. Based on testing three
samples each of the cyanoacrylate and fibrin glue, the average breaking strength of the
cyanoacrylate was about 150 times greater than the fibrin glue [36]. However, the
flexibility of the fibrin glue was vastly better than the cyanoacrylate. The results of this
study showed that the n-butyl-2-cyanoacrylate glue was characterized by a greater
mechanical strength than its fibrin counterpart but lacked the flexibility to conform to the
shape of tissue.
Duffy et al. used a MTS Material Strength Testing Machine to evaluate the
breaking loads of extraocular muscles adhered to other ocular tissues with 2-octyl
cyanoacrylate, a scaffold-enhanced 2-octyl cyanoacrylate adhesive, and the natural
adhesion of the two tissues [7]. Two to five minutes after the tissue adhesion preparation,
the samples were clamped to the strength testing machine with pneumatic grips and
attached to a 100 N load cell [7]. The samples were pulled at a constant rate of one
gravitational force per second until complete separation of the two tissues [7]. The
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maximum load was obtained when the two tissues completely separated [7]. Table 4
shows the average breaking loads of extraocular muscle-to-sclera, sclera-to-sclera, and
extraocular muscle-to-extraocular muscle adhesions when certain sample adhesives were
and were not applied. All three adhesions indicate that the scaffold-enhanced 2-octyl
cyanoacrylate adhesive required a larger load to break the adhesion between the tissues
than 2-octyl cyanoacrylate alone. The native extraocular muscle-to-extraocular muscle
adhesion required a larger load to completely separate the two tissues than 2-octyl
cyanoacrylate alone and a scaffold-enhanced 2-octyl cyanoacrylate adhesive [7].
Table 4. The mean breaking loads with the standard deviations measured in grams.
PLGA and SIS were scaffolds used in conjunction with the 2-octyl cyanoacrylate
adhesive that required a higher breaking load to separate the two tissues [7].
(Reprinted from J. AAPOS, 9, M.T. Duffy, J.N. Bloom, K.M. McNally-Heintzelman,
D.L. Heintzelman, E.C. Soller and G.T. Hoffman, Sutureless Ophthalmic Surgery: A
Scaffold-Enhanced Bioadhesive Technique, 315-320, 2005, with permission from
Elsevier)
2-Octyl
2-Octyl
2-Octyl
Cyanoacrylate Cyanoacrylate Cyanoacrylate
Alone
+ PLGA
+ SIS
Native Muscle
Extraocular Muscle-toSclera Adhesions (g) 248 ± 43
Sclera-to-Sclera
Adhesions (g)
251 ± 37
Extraocular Musclesto-Extraocular Muscle
Adhesions (g)
369 ± 35

2.11

432 ± 21

424 ± 23

257 ± 41

404 ± 21

399 ± 24

N/A

561 ± 21

571 ± 24

631 ± 36

Adhesive Force
When assessing the adhesive force of a tissue adhesive not on tissue, two types of

peel tests are commonly performed. The first type of test is the single-arm 90° peel test.
This version of the peel test has a rigid base plate bolted onto a linear bearing, which is
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mounted on a universal testing machine [37]. The free part of the peel arm is bent around
a roller so that it can be clamped by the upper grip of the testing machine and can provide
a 90° peel angle [37]. The peel test is conducted by peeling the peel arm with a constant
crosshead speed measured in millimeters per minute [37]. The force required to fracture
the adhesive bond is obtained at the conclusion of this test. Figure 13 portrays the
concept of a single-arm 90° peel test.

Figure 13. The single-arm 90° peel test. The height of the adhesive and peel arm are
represented by ha and hs, respectively. The peel angle with respect to the load line is
denoted by θ. The load experienced when pulling the adhesive is represented by P [37].
(Reprinted from Eng. Fract. Mech., 73, H. Hadavinia, L. Kawashita, A.J. Kinloch, D.R.
Moore and J.G. Williams, A numerical analysis of the elastic-plastic peel test, 23242335, 2006, with permission from Elsevier)
The second type of peel test is the T-peel test. This kind of peel test attaches the
adhesive sample between the peel arms of the universal testing machine, and the peel
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arms are allowed to rotate freely [37]. Unlike the single-arm 90° peel test, the T-peel test
has both peel arms pull apart from the vertical axis and the force required to fracture the
adhesive bond is measured [37]. The crosshead speed remains constant measured in
millimeters per minute. Figure 14 illustrates how the T-peel test works.

Figure 14. The T-peel test. The peel arms are perpendicular to the horizontal axis. The
load experienced when pulling the adhesive is represented by P [37]. (Reprinted from
Eng. Fract. Mech., 73, H. Hadavinia, L. Kawashita, A.J. Kinloch, D.R. Moore and J.G.
Williams, A numerical analysis of the elastic-plastic peel test, 2324-2335, 2006, with
permission from Elsevier)
Lee and Tsao used the single-arm 90° peel test to measure the adhesive force.
They used a Lloyd LRX Universal Tester to measure the adhesive force and set the
crosshead speed at 30 mm/min [25]. The adhesive force for various concentrations of
silver nanoparticles in the hydrogel is tabulated in Table 5. The results from the test
showed that the increase of silver nanoparticle concentration yields a slight decrease in
adhesive force.
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Table 5. The adhesive force for various concentrations of silver nanoparticles in the
hydrogel. As there was an increase of silver nanoparticle concentration in parts per
million in the hydrogel, the adhesive force slightly decreased [25]. (Reprinted from J.
Mater. Sci., 45, W-F. Lee and K-T. Tsao, Effect of silver nanoparticles content on the
various properties of nanocomposite hydrogels by in situ polymerization, 89-97,
2010, with permission from Springer Science and Business Media)
Silver Nanoparticle Concentration (ppm)
0
55.6
83.4
111.2
139

2

Adhesive Force (g/cm )
16.73 ± 0.3%
16.32 ± 1.6%
16.22 ± 1.3%
15.61 ± 0.7%
14.99 ± 0.2%

Chivers et al. evaluated the adhesive properties of several common tissue
adhesives, such as cyanoacrylate, gelatin-based adhesive, and fibrin [38]. They tested the
adhesive strength of the adhesive to porcine skin, bone, and cartilage. Porcine skin is a
common substrate used for measuring adhesive properties of an adhesive. Adhesive was
applied in between overlapping skin and then allowed to cure. This specimen was then
clamped by the grips of the universal testing machine and pulled at 5 mm/min until the
bond completely failed [38]. The strength of the adhesive was highly dependent on the
test substrate. As shown in Table 6, cyanoacrylate displayed the greatest adhesive
strength over gelatin-based adhesive and fibrin [38].
Table 6. The mean adhesive force for the three adhesives bonded to the three different
substrates. Cyanoacrylate showed the greatest adhesive strength [38]. (Reprinted
from Int. J. Adhes. Adhes., 17, R.A. Chivers and R.G. Wolowacz, The strength of
adhesive-bonded tissue joints, 127-132, 1997, with permission from Elsevier)

n-Butyl-2-cyanoacrylate
Gelatin/resorcinol/formaldehyde
Fibrin

Adhesive Strength (MPa)
Cartilage
Bone
1.00
1.40
0.15
0.20
0.0049
0.0110
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Skin
1.20
0.07
0.0190

2.12

Curing Time
Cyanoacrylate tissue adhesives polymerize on contact with moisture such as water

and blood [10,11]. Upon contact with liquid substances, a strong bond is formed between
the adhesive and tissue. The application of one drop of 2-octyl cyanoacrylate as a smooth
single layer on the wound takes 15 to 30 s to fully polymerize and dry [11]. When
increasing the droplet amount of 2-octyl cyanoacrylate to two to three drops, it takes two
minutes to fully polymerize and dry as a thin, uniform layer on the wound [10].
2.13

Transparency
After the polymerization and drying time of 2-octyl cyanoacrylate, Meskin et al.

reported that a gray-to-white meshwork of the adhesive formed on the corneal wound as a
barrier [11]. The 51 patients involved with this study did not report any obstruction of
vision or decline of visual acuity after the adhesive was applied. During the second
postoperative visit after cataract surgery, 8 of the 51 patients experienced mild staining
on the clear corneal wound edges or a mildly irregular epithelium [11]. Nevertheless,
Meskin and his group reported that all patients met the safety criteria and regained their
vision soon after the procedure.
2.14

Summary
Tissue adhesives are a safe and effective alternative to sutures when treating

wounds around the body. Due to the delicate nature of ocular tissue, tissue adhesives will
not inflict any mechanical damage onto the eye. The desirable mechanical and
antibacterial properties suggest that a silver nanoparticle-infused tissue adhesive would
minimize wound healing time and reduce the possibility of infection.
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The areas investigated in this literature review offer insights on how to develop a
silver nanoparticle-infused tissue adhesive for ophthalmic use. The tissue adhesive with
a short curing time and favorable sealing and mechanical properties is 2-octyl
cyanoacrylate. The size, shape, and concentration need to be considered because of its
relevance in determining the antibacterial effectiveness of silver nanoparticles. With
these parameters discussed in this chapter, a functional silver nanoparticle-infused tissue
adhesive for ophthalmic use was developed in this research.
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CHAPTER THREE
OBJECTIVE
3.1

Objective
The objective of this research was to evaluate the effects of silver nanoparticle

infusion on the antibacterial efficacy, adhesive strength, and breaking strength of a 2octyl cyanoacrylate tissue adhesive as a function of nanoparticle size and concentration.
Before evaluating the antibacterial and mechanical properties of the silver nanoparticleinfused tissue adhesive, uniform distribution of the silver nanoparticles in the adhesive
needed to be achieved. The antibacterial effectiveness of the composite adhesive was
determined via the Kirby-Bauer disk diffusion susceptibility test and CFU counting. The
adhesive force to a porcine sclera and breaking load of the silver nanoparticle-infused 2octyl cyanoacrylate tissue adhesive were the mechanical properties evaluated. Generated
results from these tests were compared to the results of a control sample composed of an
unaltered version of the 2-octyl cyanoacrylate tissue adhesive.
3.2

Justification
Tissue adhesives are safe alternatives to mechanical fasteners when treating

ocular wounds. Using sutures on delicate ocular tissue or allowing self-healing increases
the risk of infection and healing time. Currently, tissue adhesives are used for ophthalmic
applications; however, the potential for infection is still present if the wound is not
properly cleansed. The addition of silver nanoparticles to a 2-octyl cyanoacrylate tissue
adhesive was proposed to reduce the potential for infection.
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CHAPTER FOUR
MATERIALS AND METHODS
4.1

Overview
A 2-octyl cyanoacrylate tissue adhesive provides a safe alternative to using

mechanical fixtures when treating wounds. Using mechanical fixtures on tissue causes
discomfort to patients and occasionally inflicts damage beyond what is necessary [6].
Furthermore, there is a risk of inflammation or infection on the wound when using
mechanical fixtures. If a tissue adhesive is used to treat an improperly cleansed wound,
there is also a possibility of inflammation and infection. The infusion of silver
nanoparticles into a 2-octyl cyanoacrylate was proposed to reduce the potential for
infection because of the notable bactericidal effect of silver nanoparticles.
4.2

Materials
The two main materials tested in this experiment were silver nanoparticles and a

2-octyl cyanoacrylate tissue adhesive. The 4 nm and 10 nm size silver nanoparticles
(NanoXact, nanoComposix) were dried powders redispersed in 99.7+% chloroform (IBI
Scientific) and 99.5+% anhydrous ethanol (Fisher Scientific), respectively. The brand of
the 2-octyl cyanoacrylate tissue adhesive was Dermabond® (Ethicon, Inc.), which is a
high viscosity tissue adhesive that comes in individual 0.5 mL vials. All samples that
needed to be specifically shaped for their respective tests were formed in a
polyacrylamide mold, which was composed of 99.9% N,N’-methylenebisacrylamide
(bisacrylamide; UltraPure™, Life Technologies), 98.5+% acrylamide (Fisher Scientific),
98% ammonium persulfate (APS; Fisher Scientific), 95+% N,N,N',N'-
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tetramethylethylenediamine (TEMED; Fisher Scientific), and deionized water. For the
antibacterial testing, E. coli (San José State University, Department of Biological
Sciences) were the bacteria used and were incubated on a solid LB agar (Miller, Fisher
Scientific) and LB broth (Lennox, Fisher Scientific) filled culturing dish. In the breaking
load testing of the experiment, the silver nanoparticle-infused tissue adhesive was molded
into a dog-bone shaped specimen. For the adhesive force testing, the composite adhesive
was applied onto the sclera of a porcine eye (Mi Pueblo Food Center). The porcine eyes
were kept in sterile Ringer’s solution and were stored in a refrigerator. The Ringer’s
solution was composed of sodium chloride, potassium chloride, and calcium chloride.
The handling and disposal of porcine eyes was in compliance with the regulations set
forth by the San José State University Institutional Animal Care and Use Committee
(IACUC).
4.3

Equipment
The silver nanoparticles were dispersed into the adhesive with a vortex (S/P®

Vortex Mixer, Baxter Diagnostics Inc.) and indirect sonicator. The composite adhesive
sample container was placed in a cold water bath and ultrasonic energy was propagated
through the medium via the sonicator. Transmission electron microscopy (1010, JEOL)
produced high resolution images of the sample to ensure the uniform distribution of the
silver nanoparticles within the adhesive.
An autoclave (SS-320, Tomy) sterilized the liquid media used for the
experiments. The antibacterial testing portion of the experiment required the handling of
bacteria in a biosafety cabinet (1100, Forma Scientific). An incubator (B 5060, Heraeus
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Instruments) was used to grow the bacterial colonies and also incubate the bacteria with
the silver nanoparticle-doped adhesive. An inverted microscope (Eclipse Ti, Nikon) was
used to observe the inhibition halos surrounding the adhesive samples for the KirbyBauer disk diffusion susceptibility test. To test the breaking load and adhesive force of
the adhesive, an Instron (4204) universal testing machine was the analytical instrument
used. The adhesive force setup also included securing a porcine eye in a vacuum eye
holder that was connected to an Edwards (RV12) rotary vane pump for vacuum suction.
The vacuum eye holder was comprised of everyday items, such as a wooden frame,
tubing, ½” x ¾” pipe adapter, and ½” barb elbow fitting that are typically used for a
water sprinkler system (Orbit Sprinklers). The pipe adapter held the eye while the barb
elbow fitting connected the adapter to the tubing connected to the rotary vane pump. The
experiments were performed at San José State University.
4.4

Materials and Equipment Safety
Personal protective equipment (PPE) was worn when handling all of the materials

involved in this experiment. The PPE worn included nitrile gloves, goggles, lab coat,
long sleeve shirt, pants, and closed-toe shoes. Before preparing and conducting any of
the experiments, training for using the equipment and materials was conducted. Table 7
organizes the safety precautions for the materials necessary for this experiment.
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Table 7. Safety precautions for each material used in this experiment. These
precautions include hazards, handling, storage, emergency response plan, spill and
leak procedures, and waste disposal procedures.
Material

Hazards

Skin, eyes,
Silver
respiratory,
nanoparticles digestive tract
irritant [39]

Handling
PPE, avoid
inhalation and
ingestion [39]

Emergency
Spill and Leak
Response Plan Procedures
Sweep, dilute
Store in closed
For fire, use
with water, wipe
bottle, store at 2water, carbon
surface with
25°C away from
dioxide [39]
cleaner [39]
light [40]
Storage

Store below
30°C away from
moisture, heat
[41,42]
PPE, avoid
Store in closed
Skin, respiratory,
inhaling vapors, container in a
LB agar and
digestive tract
eye and skin
dry, ventilated
LB broth
irritant [43,44]
contact [43,44] area [43,44]

2-octyl
Polymerizes
cyanoacrylate rapidly on contact PPE [41]
Dermabond® with tissue [41,42]

PPE, use fume
hood, avoid eye
and skin contact,
inhalation [49]
PPE, use fume
hood, avoid eye
and skin contact,
inhalation [50]
PPE, use fume
hood, avoid eye
and skin contact,
inhalation [51]

Keep in a dry,
ventilated area,
away from
flammables [51]

Biohazard if not PPE, frequent
handled properly hand washing

Flammable,
carcinogen. Skin,
eye, respiratory
irritant [46]
Carcinogen. Skin
Chloroform and eye irritant
[47]
Causes genetic
damage, infertility,
Acrylamide allergic reaction.
Neurotoxin,
carcinogen [48]
Eye, skin irritant.
Causes
Bisacrylamide
reproductive harm
[49]
Combustible,
Ammonium organic material.
persulfate
Respiratory, skin,
eye irritant [50]
Causes burns,
pulmonary edema.
TEMED
Harmful if inhaled,
ingested.
Flammable [51]
Anhydrous
Ethanol

Wash eyes,
skin with water
[43,44]

Polymerize with
water, pick up
with inert
material [41,42]
Sweep up and
dispose in
closed container
[43,44]
Absorb spill
with paper
towel, sodium
hypochlorite
[45]
Dispose in
biohazard
container
Contain spillage,
place in
appropriate
container [46]
Contain spillage,
place in
container [47]
Wear breathing
apparatus,
protective suit.
Sweep into
container [48]
Sweep or
vacuum into
suitable
container [49]

Electrolyte
fluid therapy,
use antibiotics
in severe cases
[45]
Contact
Refrigerate in
physician if
Ringer's solution
become sick
Store in closed
For fire, use
container away
water, carbon
from flammables
dioxide [46]
[46]
Store in closed Wash skin and
container away eyes with
from light [47] water [47]
Store in closed
Rinse eyes,
container,
wash skin with
refrigerate, away
soap and
from sunlight
water [48]
[48]
Rinse eyes,
Keep in a cool,
wash skin with
dry, ventilated
soap and
area [49]
water [49]
Keep in a cool, Rinse eyes,
Sweep, vacuum
dry, ventilated wash skin with
into suitable
area, away from soap and
container [50]
flammables [50] water [50]

Causes
PPE, frequent
Escherichia hemorrhagic
hand washing
coli
colitis, abdominal
[45]
pain [45]
Porcine eyes

Use petroleum
jelly to loosen
bond on skin
[41]

PPE, avoid
inhaling vapors
or mist [46]
PPE, avoid
inhaling vapors
[47]
PPE, use fume
hood, avoid eye
and skin contact,
inhalation [48]

Store in
appropriately
labeled sealed
containers [45]
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Rinse eyes,
wash skin with
soap and
water [51]

Waste Disposal
Procedure
Dispose of
according to
regulations [39]
Dispose in nonhazardous solid
waste [41]
Give product to
disposal
company
[43,44]
Decontaminate,
sterilize,
disinfect [45]
Dispose in
biohazard
container
Dispose via
waste disposal
service [46]
Dispose of
according to
regulations [47]
Dispose of
according to
regulations [48]
Dispose of
according to
regulations [49]
Dispose of
according to
regulations [50]

Absorb with
Dispose of
inert material.
according to
Keep in suitable
regulations [51]
container [51]

Formal training before operating the equipment used in this experiment was
conducted to educate the operator of potential hazards and to teach proper usage. When
using a sonicator, the operator needed to wear earplugs to protect his ears from the high
frequency of the ultrasonic energy. The autoclave also possesses hazards if not properly
used. Since a high temperature and pressure were set during sterilization, the autoclave
was allowed to cool before opening [52]. The operator needed to stand back and open
the door slowly to let the extra steam escape [52]. Once these precautions were taken,
thick gloves were used to remove the hot items [52].
The rotary vane pump created a vacuum by the rotation of the pump-motor inside
the containing cavity [53]. Oil was used to lubricate the moving parts of the pump and
posed as a safety hazard. The operator needed to avoid prolonged skin contact and
inhaling the oil mist [53]. Furthermore, the instrument casing was hot during and after
operation and can cause burns if carried [53]. The operator needed to be careful of
moving parts when using the universal testing machine.
4.5

Experimental Methodology

4.5.1

Experimental Matrix
To fulfill the objective of this research, the antibacterial effectiveness, breaking

load, and adhesive force of the silver nanoparticle-infused tissue adhesive were
measured. The two measured factors were the silver nanoparticle concentration and size.
These factors were each measured at a high and low level. For the silver nanoparticle
concentration, the high and low level concentrations were 10 μg/mL and 1 μg/mL,
respectively. The high and low silver nanoparticle size levels were 10 nm and 4 nm,
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respectively. These factors and levels are organized in an experimental matrix in Table 8
to aid in designing an experiment that demonstrates the effect of silver nanoparticle
concentration and size on the antibacterial efficacy, breaking load, and adhesive force of
the 2-octyl cyanoacrylate tissue adhesive.
Table 8. The experimental matrix containing varying levels of each factor. Since
there were two factors being varied, there were four runs that were conducted for
each test. A control sample was also evaluated for each test. The plus (+) sign
represents a high level, and the minus (-) sign represents a low level.
Standard Order
1
2
3
4

Silver Nanoparticle Concentration
+
+

Silver Nanoparticle Size
+
+

Each of the three tests used 2-octyl cyanoacrylate alone as a control. The
experiment was conducted five times to ensure reliability of the data. Repeating the
experiment provided varying ranges of response data and allowed for the determination
of errors in each run. Data analysis was performed to conclude the effect silver
nanoparticle concentration and size has on the adhesive’s antibacterial and mechanical
properties. Additionally, the responses of the tissue adhesive containing varying factors
were compared to the responses generated by the tissue adhesive alone. These response
comparisons established if the infusion of silver nanoparticles into the 2-octyl
cyanoacrylate tissue adhesive was advantageous over the tissue adhesive alone. To
summarize the steps involved in this experiment, Figure 15 shows a flowchart depicting
each step of the experimental process.
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Figure 15. Flowchart illustrating the steps involved with this experiment.
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4.5.2

Infusion of Silver Nanoparticles into the Tissue Adhesive
Varying concentrations and sizes of silver nanoparticles were added to a 2-octyl

cyanoacrylate tissue adhesive via vortexing and indirect sonication. Vortexing provided
initial mixing of the silver nanoparticles into the liquid tissue adhesive. Indirect
sonication was used because the ultrasonic energy evenly disperses the nanoparticles
within the tissue adhesive. Results will be subject to additional variability and will not be
repeatable if the silver nanoparticles were not evenly distributed within the tissue
adhesive. These dispersion techniques were important to this experiment because of the
relatively quick polymerization of 2-octyl cyanoacrylate on contact with moisture.
Typically, dried silver nanoparticles must first be added to a solvent and vortexed and
sonicated to be dispersed and unagglomerated.
The 10 nm silver nanoparticle surfaces were received from the manufacturer
coated with polyvinylpyrrolidone to prevent agglomeration after dispersion into a polar
solvent. There are a variety of polar solvents in which silver nanoparticles are soluble.
Since 2-octyl cyanoacrylate quickly polymerizes when in contact with moisture, an
anhydrous solvent was the best choice to slow the polymerization and allow for more
control of the adhesive. An anhydrous, 200 proof, 99.5+% ethanol was used as the
solvent to allow high solubility for the silver nanoparticles. The 4 nm silver
nanoparticles has a dodecanethiol capping agent. These organically functionalized silver
nanoparticles can be redispersed in various polar organic solvents. A 99.7+% chloroform
was the selected solvent because of the high solubility of silver nanoparticles in this
solvent and its relative safety compared to other polar organic solvents. These coatings
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should displace from the silver nanoparticles when added to the appropriate solvent [54].
The solvents were added to their respective silver nanoparticle containers and were
vortexed for 10 s and sonicated for 30 s to produce a homogenous solution. The solvents
were not added to the unaltered adhesive control samples.
Vortexing and indirect sonication were ideal methods to disperse the small
amounts of 2-octyl cyanoacrylate and silver nanoparticles used in these experiments.
This was because vortexing and sonicating provided quick and homogeneous mixing of
the silver nanoparticles into the adhesive. Indirect sonication was also ideal because of
the reduction of heat resulting from direct ultrasonic energy. Indirect sonication involved
the immersion of the liquid sample container into a cold water bath while ultrasonic
waves were sent through the bath [29]. Continuous mode operation was adequate for
dispersing the nanoparticles within the adhesive. The tissue adhesive and redispersed
silver nanoparticles were added to a 1.5 mL microcentrifuge tube and were vortexed for
10 s and indirectly sonicated for 30 s to obtain a homogeneous solution. If the
nanoparticle and adhesive mixture was not homogeneous, additional vortexing and
sonication was performed. Figure 16 shows the addition of silver nanoparticles to the
adhesive before and after vortexing and sonication.
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Figure 16. The addition of silver nanoparticles to the tissue adhesive prior (top) and after
(bottom) vortexing and sonication.
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4.5.3

Silver Nanoparticle Distribution Within Adhesive
The distribution of silver nanoparticles within the tissue adhesive was observed

with a TEM. The TEM images the transmitted beam of electrons through the sample to
generate an image of the silver nanoparticles within the tissue adhesive [55]. A 0.5 mL
vial of the adhesive and 0.5 mg container of dried 10 nm silver nanoparticles were sent
for TEM analysis (nanoComposix). The anhydrous ethanol was not sent along with the
adhesive and nanoparticles because of the possible container breakage and exposure of
the flammable ethanol to an ignition source. The silver nanoparticles were redispersed in
anhydrous ethanol by the tester. We provided instructions on how to prepare the
composite sample as we would for our testing. The silver nanoparticle composite
adhesive was prepared by adding 50 μL of adhesive to a container holding 10 μg/mL of
silver nanoparticles, vortexing for 10 s, and indirectly sonicating for 30 s to obtain a
homogeneous solution. Image acquisition was performed and images were sent back for
our use. ImageJ, which is an image processing and analyzing program developed by the
National Institutes of Health (NIH), was used to evaluate the distribution of particle
spacing. First, the scale was set to the length of the scale bar from the provided image.
The Line tool was used to draw a line from the center of a particle to the center of an
adjacent particle. The length of the line was measured by ImageJ and the results of the
analysis were displayed. Measuring the spacing between particles were performed for all
particles and ultimately summarized by the ImageJ software.
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4.5.4

Preparing Samples in Polyacrylamide Mold
A polyacrylamide mold was used to shape the samples for their respective testing.

Polyacrylamide was chosen due to its water content, which aids in the polymerization of
the 2-octyl cyanoacrylate adhesive when poured into the mold and can be rehydrated if
needed. Polyacrylamide was also chosen to be the mold because of its flexibility that
allowed easy removal of samples from the mold. The mold formed the disks and dogbone shaped specimens for the Kirby-Bauer test and breaking load test, respectively.
This polyacrylamide mold was created by being formed on an inverted solid mold. The
disk and dog-bone shapes on the solid mold were extruded outward to form the
polyacrylamide mold, which allowed the adhesive to be poured into the mold. The disks
used for the Kirby-Bauer test had a diameter of 6.35 mm and a thickness of 1.5875 mm.
The dog-bone specimens used for the breaking load test have a reduced section of 6.35,
1.5875, and 1.5875 mm as the length, width, and thickness, respectively. Bulk highdensity polyethylene (HDPE) was machined to create the solid mold and is pictured in
Figure 17.
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Figure 17. Machined high-density polyethylene (HDPE) solid mold used to form the
polyacrylamide mold for preparing samples for the breaking load test.
Refining the formulation of the polyacrylamide mold to the desired flexibility and
durability required multiple attempts. Since unpolymerized acrylamide is a neurotoxin,
every step of this procedure was performed in a fume hood. The bottom of the solid
mold was taped to a 100 mm diameter culturing dish using double-sided tape before
preparing the polyacrylamide solution. In order to create a 20 mL solution of acrylamide,
0.0199 g of bisacrylamide was added to 3.9801 g of acrylamide and mixed with
deionized water until reaching 20 mL. In a separate container, 0.2 g of APS was added to
2 mL of deionized water. The APS was then mixed with the acrylamide solution.
Quickly afterward, 7 μL of TEMED was dispensed into the acrylamide and APS mixture
and stirred vigorously before being poured into the culturing dish containing the solid
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mold. APS and TEMED catalyzed the polymerization of acrylamide and generated the
polyacrylamide in 30 min. Figure 18 depicts the freshly made polyacrylamide mold.

Figure 18. The polyacrylamide mold used to form the samples used for breaking load
testing. The mold was placed in a 100 mm diameter culturing dish.
4.5.5 Antibacterial Effectiveness Testing
Before testing the antibacterial efficacy of the composite tissue adhesive, E. coli
fed with LB broth was grown on sterilized solid agar within a culturing dish. LB broth
was prepared by mixing 25 g of the powder to 1,000 mL of deionized water. Similarly,
LB agar was prepared by mixing 37 g of the powder to 1,000 mL of deionized water.
These amounts and volumes were general ratios and were scalable to whatever final
volume of material needed. The LB broth and LB agar were then placed into the
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autoclave for 20 min at 121°C to be sterilized. Upon completion of sterilization, the
containers of broth and agar were removed and set aside to be cooled down. The agar
was poured into 60 mm diameter culturing dishes when the agar was slightly cooled to be
safely held and poured but remained at low viscosity. The agar gradually solidified and
was placed into the refrigerator along with the LB broth.
The Kirby-Bauer test sample preparation started by adding a colony of E. coli to
10 mL of LB broth within a 15 mL conical centrifuge tube and placed in an incubator at
37°C for 16 h. The conical centrifuge tube was taken out after the time has elapsed and
vortexed for five seconds. A single-channel adjustable pipet was used to pipet 25 μL of
the E. coli in LB broth solution onto the solidified agar within the culturing dish. The
narrow portion of a glass Pasteur pipet was flamed and bent into a L-shape to be used to
spread the E. coli in LB broth solution on the agar. Next, the adhesive samples were
prepared on a polyacrylamide mold. After the 6.35 mm diameter by 1.5875 mm thick
disk-shaped sample was formed, the sample was placed onto the culturing dish and
incubated for 16 h at 37°C. During the 16 h of incubation, the sample absorbs water from
the agar plate while the silver diffuses into the surrounding agar [26,34]. If the bacteria
were susceptible to the antibacterial property of silver nanoparticles, then an inhibition
halo formed around the composite adhesive sample. To prove the antibacterial
effectiveness of the silver nanoparticles, a disk of unaltered tissue adhesive served as a
control, which should not produce an inhibition halo. We hypothesized that altering
silver nanoparticle concentration and size will affect the diameter of the inhibition halo,
thus indicating variation in antibacterial efficacy. The determination of the presence of
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an inhibition halo surrounding the samples was observed after 16 h. All inhibition halo
diameters of the samples were measured with a caliper and recorded.
CFU counting was another quantitative measurement of antibacterial
effectiveness of the silver nanoparticle-imbued 2-octyl cyanoacrylate tissue adhesive.
The samples from the Kirby-Bauer test were prepped to be used for the CFU counting
test. The samples from that test were first added to 10 mL of LB broth within a 15 mL
conical centrifuge tube, which was vortexed for 10 s and indirectly sonicated for 30 s.
Vortexing and sonication was repeated two more times. This solution was diluted to five
different orders of magnitude: 10-1, 10-2, 10-3, 10-4, and 10-5. To dilute the solution to 101

, 100 μL of the sample solution from the conical centrifuge tube was drawn by a single-

channel adjustable pipet and dispensed into a 1.5 mL microcentrifuge tube containing
900 μL of LB broth. The new diluted solution was aspirated and dispensed three times in
the microcentrifuge tube to ensure thorough mixing. Next, 100 μL of this diluted
solution was drawn, dispensed, and mixed into another 1.5 mL microcentrifuge tube
containing 900 μL of LB broth to produce the 10-2 diluted solution. This process was
repeated until reaching the 10-5 diluted solution. After all dilutions were completed, 25
μL of the 10-5 diluted solution was dispensed onto solid agar within a culturing dish and
was spread with a flamed, L-shaped glass Pasteur pipet. This spreading of diluted sample
solution was repeated for the 10-4 dilution all the way to 10-1 in that sequential order. The
culturing dishes were then placed into the incubator for 18 h at 37°C. This entire sample
preparation process was repeated for all adhesive samples. After the incubation time, the
culturing dishes were removed from the incubator and the E. coli colonies of each dish
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were counted. There should be a noticeable reduction of colonies as the samples were
more diluted. We hypothesized that an unaltered version of 2-octyl cyanoacrylate will
produce a higher CFU count than the silver nanoparticle-doped tissue adhesive samples.
Pictures of the samples were taken with a camera (DSC-P200, Sony) at 1X magnification
to be processed and analyzed in ImageJ.
4.5.6 Breaking Load Testing
The breaking load of the silver nanoparticle-infused tissue adhesive was measured
with the universal testing machine. Samples were prepared by dispensing the adhesive
into the individual dog-bone shaped mold on the polyacrylamide mold to polymerize and
dry. After the adhesive polymerized, each end of the sample was clamped by the
pneumatic grips of the universal testing machine, which is shown in Figure 19. The user
entered 6.35, 1.5875, and 1.5875 mm as the length, width, and thickness of the reduced
section of the adhesive sample into Instron’s Bluehill® 3 instrument software before the
test began. The universal testing machine was equipped with a 100 N load cell to detect
the breaking load of the composite adhesive, which was found when the sample fractured
and completely separated. The sample was pulled apart by the universal testing machine
at a rate of 1 mm/min until the sample fractured. The raw data was recorded and initially
analyzed by the Bluehill® 3 software. The raw data was obtained and further analyzed in
Microsoft Excel to assess the effects of silver nanoparticles on the breaking load of the
tissue adhesive.
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Figure 19. Dog-bone shaped specimen clamped by the grips of the universal testing
machine. The adhesive sample’s length, width, and thickness of the reduced section were
6.35 mm, 1.5875 mm, and 1.5875 mm, respectively.
4.5.7 Adhesive Force Testing
This test examined the adhesive force of the composite tissue adhesive on porcine
eye tissue. First, a 3.0 mm incision was made on the sclera of the porcine eye. A 50 μL
amount of adhesive was then applied as a smooth single layer to the incised ends of the
sclera while the two ends of the tissue were held together. A machined T-structure was
attached to the other side of the adhesive and the operator applied force to the bonded
area for five minutes to allow the adhesive to polymerize. Figure 20 shows the T-
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structure attached to the porcine sclera. The T-structure was wooden because the wood
will not fracture before the adhesive bond fractures. The eye was then placed into a
vacuum eye holder and rotated in a way such that the area of the incised sclera was not
secured by the eye holder. The eye holder is pictured in Figure 21. The eye holder was
tightened by the lower grip of the universal testing machine and connected with a tube to
the rotary vane pump that provided vacuum suction. Figure 22 illustrates the setup for
the adhesive force testing.

Figure 20. The T-structure adhered to the porcine sclera prior to placing into the vacuum
eye holder. The bonding surface of the T-structure was 13 mm wide and 13 mm long.
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Figure 21. The eye holder that held the eye in the pipe adapter. The tube connected the
eye holder to the rotary vane pump to provide vacuum suction.
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Figure 22. The adhesive force experimental setup. The rotary vane pump was positioned
on the cart (far left), while the eye holder was clamped onto the universal testing
machine.
The upper pneumatic grip was lowered until the vertical section of the T-structure
was clamped to the grips. The operator entered the length, width, and thickness of the
bonded area of the adhesive to the eye into the Bluehill® 3 software before testing
started. The 100 N load cell was also used for this test and was pulled at a rate of 5
mm/min until the adhesive bonds between the porcine eye and the adhesive fractured.
The force required to break the adhesive bonds is called the adhesive force. Similar to
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the other performed tests, an unaltered tissue adhesive was used as a control. The raw
data was generated by the Bluehill® 3 software and Microsoft Excel was used to evaluate
the effects the silver nanoparticles has on the adhesive force of the tissue adhesive when
tested on porcine eyes.

64

CHAPTER FIVE
RESULTS
5.1

Silver Nanoparticle Distribution within Tissue Adhesive
The TEM images showed uniform distribution of the silver nanoparticles within

the 2-octyl cyanoacrylate. Figure 23 displays the distribution of the 10 nm silver
nanoparticles within the tissue adhesive. The spacing between the particles for four TEM
images was on average 37.2 nm, with a standard deviation of 14.4 nm. The raw data for
the ImageJ analysis of the spacing between particles are located in Appendix A. The 4
nm and 10 nm silver nanoparticles were also imaged to confirm the particle size. The 4
nm particle size is pictured in Figure 24, while the 10 nm particle size is shown in Figure
25. The 4 nm and 10 nm particle sizes represented the median sizes. In terms of the
silver nanoparticle size distribution, the 10 nm nanoparticles exhibited a 12.3%
coefficient of variation, while the 4 nm nanoparticles exhibited a 15.6% coefficient of
variation.
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Figure 23. TEM image of the 10 nm silver nanoparticles distributed within 2-octyl
cyanoacrylate. The image is at 80,000X magnification.
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Figure 24. TEM image of the 4 nm silver nanoparticles to confirm the particle size. The
image is at 100,000X magnification.

Figure 25. TEM image of the 10 nm silver nanoparticles to confirm the particle size. The
image is at 80,000X magnification.
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5.2

Antibacterial Efficacy
We hypothesized that the infusion of silver nanoparticles into the 2-octyl

cyanoacrylate tissue adhesive imbues an antibacterial effect to the adhesive. The KirbyBauer disk diffusion susceptibility test and CFU counting were performed to examine this
composite adhesive and compared it to an unaltered version of the tissue adhesive.
Results indicate that the composite adhesive was characterized by a notable decrease of
bacterial growth than compared to the tissue adhesive alone. The following sections
describe the results of the individual antibacterial tests.
5.2.1 Kirby-Bauer Disk Diffusion Susceptibility Test
The objective of this test was to observe if an inhibition halo was present around
the disk-shaped sample that was placed on top of a culturing dish filled with E. coli. As
expected, none of the unaltered 2-octyl cyanoacrylate samples produced a surrounding
inhibition halo. The absence of an inhibition halo is seen in Figure 26. Figure 27 is a
magnified view of an unaltered adhesive sample using an inverted microscope.
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Figure 26. An inhibition halo was not formed around the unaltered adhesive.

Figure 27. Magnified view of an unaltered adhesive sample at 2X magnification. The E.
coli was confluent around the sample.
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The silver nanoparticle-infused tissue adhesive samples generated a distinct
inhibition halo surrounding each sample. This distinct inhibition halo appeared for all the
varying tested silver nanoparticle concentrations and sizes. The diameter of the
inhibition halo was measured with a caliper. Figure 28 shows a composite sample
surrounded by a distinct inhibition halo. An inverted microscope magnified the view of
the inhibition halo surrounding the sample, which is shown in Figure 29. Table 9
tabulates the average inhibition halo of the tested samples. The raw data for the KirbyBauer test are located in Appendix B. Figure 30 organizes the average inhibition halo
diameters by their respective sample combination. The error bars depict the standard
deviation of the set of data for each sample. Table 10 summarizes the results of a 2-way
analysis of variance (ANOVA) test from the responses generated in the Kirby-Bauer test.
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Figure 28. A composite sample displaying the presence of an inhibition halo.

Figure 29. Magnified view of a composite adhesive sample’s inhibition halo at 2X
magnification. Notice the distinct halo between the sample and E. coli.
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Table 9. The
T average diameter off the inhibitioon halos arouund the varioous sampless. All
runs weree performed five times.
Name

Average Inhib
A
bition Halo Standard
S
D
Diameter
(mm
m)
D
Deviation

p -valuee

Adhesive Alone

0

0

N/A

1
11.0

0
0.71

2.55E-10

1
15.2

1
1.79

3.05E-0
08

1
12.2

0
0.84

4.27E-10

1
12.0

0
0.71

1.28E-10

1 μg/mL, 4 nm
A
AgNP + Adhesive
10 μg/mL
L, 4 nm
AgNP + Adhesive
A
1 μg/mL, 10 nm
AgNP + Adhesive
A
10 μg/mL
L, 10 nm
AgNP + Adhesive
A

Inhibitiion Halo Diameteer
18

Average Diameter (mm)

16
14
12
10
8
6
4
2
0

Adhesive
Alone

1 μg/mL,, 4
nm AgNP
P+
Adhesiv
ve

10 μg/ mL, 4 1 μg/mL, 10 110 μg/mL, 10
nm AggNP + nm
m AgNP + nm AgNP +
Adheesive
A
Adhesive
Adhesive

Figure 30. Th
he average in
nhibition hallo diameter ffor various ssilver nanopaarticle-dopedd and
un
ndoped adheesives. Error bars repressent the stanndard deviatiion for each sample
co
ombination.
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Table 10. The results of a 2-way ANOVA test from the responses generated in the
Kirby-Bauer disk diffusion susceptibility test. The test statistic (F), critical value (F
crit), and p-value are shown for the size and concentration factors. The interaction of
the size and concentration factors is also shown.

Source of Variation

F

F crit

p -value

Concentration
Size
Interaction

16.3
4.08
19.8

4.49
4.49
4.49

9.48E-04
6.04E-02
4.08E-04

5.2.2 CFU Counting
CFU counting provided another test to measure the antibacterial effectiveness of
the silver nanoparticle-imbued 2-octyl cyanoacrylate tissue adhesive. This test was
conducted after the completion of the Kirby-Bauer disk diffusion susceptibility test by
taking the samples from that test and adding them to LB broth to be diluted to their
respective order of magnitude. The samples were diluted to five different orders of
magnitude: 10-1, 10-2, 10-3, 10-4, and 10-5. CFU counting allowed for quantitative
assessment of the degree of bacterial growth. The E. coli colonies were counted with
ImageJ. ImageJ detected the various colors of the image and allowed the user to adjust
the color threshold and pixel size to be counted. Allowing the operator to adjust these
parameters excluded artifactual pixels that possibly greatly alter the colony count. When
the user was not able to distinguish the number of distinct colonies in a densely populated
area on the solid agar, ImageJ separated touching colonies into segments using the
program’s Watershed algorithm and added the segmentations into the colony count. This
analysis with ImageJ was not perfect but does provide a reliable estimate of the number
of colonies. Figure 31 compiles the various samples and their respective ImageJ analysis

73

that provided a better resolution of the CFU counts. Figure 32 shows the serial dilution
of an unaltered adhesive sample, while Figure 33 shows the serial dilution of a doped
adhesive sample.

Figure 31. CFU counts for each of the different tested samples. The pictures on the top
were the colonies formed on a culturing dish after incubation. The pictures in the middle
were the adjusted color threshold that detected the desired colony colors in ImageJ. The
pictures on the bottom were the results after ImageJ analyzed the number of colonies in
the culturing dish. From left to right, the unaltered adhesive diluted to 10-2 had 1225
colonies, 1 μg/mL of 4 nm silver nanoparticles within the adhesive diluted to 10-1 had
520 colonies, 10 μg/mL of 4 nm silver nanoparticles within the adhesive diluted to 10-1
had 410 colonies, 1 μg/mL of 10 nm silver nanoparticles within the adhesive diluted to
10-1 had 610 colonies, and 10 μg/mL of 10 nm silver nanoparticles within the adhesive
diluted to 10-1 had 463 colonies.

74

Figure 32. The serial dilution of an undoped tissue adhesive.

Figure 33. The serial dilution of a silver nanoparticle-doped adhesive.
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Based on the results from the Kirby-Bauer disk diffusion susceptibility test, an
unaltered version of 2-octyl cyanoacrylate was found to have a higher CFU count than
the silver nanoparticle-infused tissue adhesive. Table 11 displays the average logarithmic
amount of E. coli colonies present on the different culturing dishes. The colony counts
were calculated in the logarithmic scale for simpler and clearer comparison. The
standard deviation and p-values were also computed. The raw data for the CFU counts
are located in Appendix C. Figure 34 compares varying concentrations and sizes of
silver nanoparticles within the tissue adhesive to the original 2-octyl cyanoacrylate. The
error bars depict the standard deviation of the set of data for each sample. Table 12
summarizes the results of a 2-way ANOVA test from the responses produced in the CFU
counting.
Table 11. The average logarithmic amount of E. coli colonies for the different types
of samples. The logarithmic values were in base 10. All runs were performed five
times.
Name

Average Number of
Colonies (Logarithmic)

Standard Deviation

p -value
(Logarithmic)

Adhesive Alone

4.88

0.16

N/A

3.89

0.13

2.44E-06

3.81

0.13

1.38E-06

3.90

0.11

1.67E-06

3.87

0.16

3.66E-06

1 μg/mL, 4 nm
AgNP + Adhesive
10 μg/mL, 4 nm
AgNP + Adhesive
1 μg/mL, 10 nm
AgNP + Adhesive
10 μg/mL, 10 nm
AgNP + Adhesive
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log(CFU/sample)

E. coli Growth
5.25
5.00
4.75
4.50
4.25
4.00
3.75
3.50
3.25
3.00

Adhesive
Alone

1 μg/mL, 4 10 μg/mL, 4 1 μg/mL, 10 10 μg/mL, 10
nm AgNP + nm AgNP + nm AgNP + nm AgNP +
Adhesive
Adhesive
Adhesive
Adhesive

Figure 34. The average CFU counts of various silver nanoparticle concentration and size
combinations within the 2-octyl cyanoacrylate tissue adhesive. Average CFU counts are
depicted on a logarithmic scale. Error bars represent the standard deviation for each
sample combination.
Table 12. The results of a 2-way ANOVA test from the responses produced in the
CFU counting. The test statistic, critical value, and p-value are shown for the size
and concentration factors. The interaction of the size and concentration factors is also
shown.

Source of Variation

F

F crit

p -value

Concentration
Size
Interaction

0.85
0.27
0.15

4.49
4.49
4.49

3.71E-01
6.12E-01
7.05E-01
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5.3

Breaking Load Testing
The breaking load of the 2-octyl cyanoacrylate increased when silver

nanoparticles were added to the adhesive. The samples were affixed to the universal
testing machine clamps and were pulled until the reduced section fractured. The raw data
recorded by the Bluehill® 3 software was obtained and analyzed in Microsoft Excel.
Table 13 displays the average breaking load for each silver nanoparticle concentration
and size combination, standard deviation, and p-values. The raw data for the breaking
load test are located in Appendix D. Figure 35 is a graph comparing the average
breaking load of the unaltered adhesive and different composite adhesives with each
other. The error bars depict the standard deviation of the set of data for each sample.
Table 14 summarizes the results of a 2-way ANOVA test from the responses generated in
the breaking load testing.
Table 13. The average breaking loads for the different factor combinations. All runs
were performed five times.
Name

Average Breaking
Load (MPa)

Standard
Deviation

p -value

Adhesive Alone

0.46

0.09

N/A

0.75

0.09

4.47E-04

1.07

0.29

9.89E-04

0.76

0.19

6.68E-03

1.46

0.33

9.46E-05

1 μg/mL, 4 nm
AgNP + Adhesive
10 μg/mL, 4 nm
AgNP + Adhesive
1 μg/mL, 10 nm
AgNP + Adhesive
10 μg/mL, 10 nm
AgNP + Adhesive
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Breaking Load (MPa)

Breaking Load
2.00
1.80
1.60
1.40
1.20
1.00
0.80
0.60
0.40
0.20
0.00

Adhesive
Alone

1 μg/mL, 4 10 μg/mL, 4 1 μg/mL, 10 10 μg/mL, 10
nm AgNP + nm AgNP + nm AgNP + nm AgNP +
Adhesive
Adhesive
Adhesive
Adhesive

Figure 35. The breaking load results of the different silver nanoparticle concentration and
size combinations within the tissue adhesive. Error bars represent the standard deviation
for each sample combination.
Table 14. The results of a 2-way ANOVA test from the responses generated in the
breaking load testing. The test statistic, critical value, and p-value are shown for the
size and concentration factors. The interaction of the size and concentration factors is
also shown.

5.4

Source of Variation

F

F crit

p -value

Concentration
Size
Interaction

22.0
3.26
3.09

4.49
4.49
4.49

2.44E-04
9.01E-02
9.80E-02

Adhesive Force Testing on Porcine Eyes
When silver nanoparticles were added to the 2-octyl cyanoacrylate adhesive, the

adhesive force increased. Figure 36 shows the fracturing of the adhesive bonds. The
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adhesive force was determined by using Microsoft Excel to analyze the raw data
generated by the Bluehill® 3 software. Table 15 tabulates the average adhesive force for
each silver nanoparticle concentration and size combination, standard deviation, and pvalues. The raw data for the adhesive force test are located in Appendix E. Figure 37
compares the average adhesive force of the unaltered adhesive samples to the different
composite adhesives. The error bars depict the standard deviation of the set of data for
each sample. Table 16 summarizes the results of a 2-way ANOVA test from the
responses produced in the adhesive force testing.

Figure 36. The broken adhesive bonds after adhesive force testing.
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Table 15. The average adhesive forces for the various factor combinations. All runs
were performed five times.
Name

Average Adhesive
Force (MPa)

Standard
Deviation

p -value

Adhesive Alone

0.008

0.002

N/A

0.010

0.001

4.462E-02

0.023

0.006

4.922E-04

0.018

0.004

7.816E-04

0.025

0.007

4.367E-04

1 μg/mL, 4 nm AgNP
+ Adhesive
10 μg/mL, 4 nm
AgNP + Adhesive
1 μg/mL, 10 nm
AgNP + Adhesive
10 μg/mL, 10 nm
AgNP + Adhesive

Adhesive Force
0.035
Adhesive Force (MPa)

0.030
0.025
0.020
0.015
0.010
0.005
0.000

Adhesive
Alone

1 μg/mL, 4 10 μg/mL, 4 1 μg/mL, 10 10 μg/mL,
nm AgNP + nm AgNP + nm AgNP + 10 nm AgNP
Adhesive
Adhesive
Adhesive + Adhesive

Figure 37. The adhesive force results of the various doped and undoped adhesives. Error
bars represent the standard deviation for each sample combination.
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Table 16. The results of a 2-way ANOVA test from the responses produced in the
adhesive force testing. The test statistic, critical value, and p-value are shown for the
size and concentration factors. The interaction of the size and concentration factors is
also shown.

Source of Variation

F

F crit

p -value

Concentration
Size
Interaction

18.3
4.26
1.38

4.49
4.49
4.49

5.77E-04
5.57E-02
2.57E-01
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CHAPTER SIX
DISCUSSION
6.1

Silver Nanoparticle Distribution within Tissue Adhesive
The distribution of the silver nanoparticles within the 2-octyl cyanoacrylate tissue

adhesive can possibly affect the variability of the results. When mixing the silver
nanoparticles into the adhesive, silver nanoparticles were positioned in the polymer
matrix such that it affected the mechanical strength of the adhesive [31,56,57]. If the
nanoparticles were not uniformly distributed within the polymer matrix, portions of the
composite sample could possibly possess higher concentrations of the nanoparticles
whereas other portions could possess lower or minimal concentrations of nanoparticles
within the matrix. For the adhesive force testing, the higher nanoparticle concentration
portion of the sample should require more force to break the adhesive bonds to the
porcine sclera. For the breaking load testing, a higher nanoparticle concentration portion
at the reduced section of the dog-bone specimen should withstand more tensile force
when the specimen is pulled apart until the reduced section fractures. In contrast,
samples containing negligible amounts of silver nanoparticles distributed at certain
portions of the polymer matrix should experience similar mechanical strength as an
unaltered version of the tissue adhesive.
6.2

Antibacterial Efficacy
Both the Kirby-Bauer disk diffusion susceptibility test and CFU counting test

revealed that the silver nanoparticles imbued antibacterial properties to the 2-octyl
cyanoacrylate tissue adhesive when mixed together. For the Kirby-Bauer test, an evident
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inhibition halo surrounded the composite samples where E. coli colonies were not found.
For the CFU counting test, the silver nanoparticle-doped adhesive significantly reduced
the number of E. coli colonies grown on the culturing dish. The difference between
composite samples and unaltered samples was statistically significant with a p-value less
than 0.01.
6.2.1 Kirby-Bauer Disk Diffusion Susceptibility Test
There was no inhibition halo surrounding the undoped adhesive samples.
Imbuing the antibacterial property of silver nanoparticles into the adhesive produced a
notably clear and distinct inhibition halo around the composite sample. This is due to the
absorption of water by the composite adhesive while the silver diffuses into the
surrounding agar during incubation [26,34]. The silver interacts with the bacterial cells
to inhibit several cell functions and injure the cells [8,58]. The growth of E. coli was
inhibited surrounding the sample because the bacteria experienced the antibacterial
property of the silver nanoparticles. The magnified microscope images of the samples
confirmed the inhibition halo around the composite sample and the E. coli growth
surrounding the unaltered tissue adhesive. The difference between doped and undoped
samples was statistically significant with a p-value less than 0.01.
The results show that the 10 μg/mL of 4 nm silver nanoparticle-doped adhesive
demonstrated the greatest bactericidal effect. With the exception of the inhibition halo
diameters of the 10 μg/mL of 4 nm silver nanoparticle-doped adhesive, the difference
between inhibition halo diameters of the all samples was minimal. A 2-way ANOVA test
was executed in Microsoft Excel and found that the silver nanoparticle concentration had
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a significant effect on the inhibition halo diameter results, while there was no significant
difference between the silver nanoparticle sizes on the results. The 2-way ANOVA test
results also showed that there was interaction between silver nanoparticle size and
concentration, which means that the response to size was dependent on the concentration
and vice versa. The effect of silver nanoparticle concentration on antibacterial efficacy
supported previous research that found an increase of silver nanoparticle concentration
enhanced antibacterial effectiveness [25]. The minimal difference in antibacterial
efficacy when varying silver nanoparticle size from 4 nm to 10 nm was possibly due to
the relatively small difference in nanoparticle size. Although the doped adhesives
demonstrated noticeable antibacterial efficacy compared to an unaltered adhesive, a
definitive conclusion cannot be drawn regarding the influence of the silver nanoparticle
size on the antibacterial efficacy of the adhesive. The CFU counting test was employed
to provide another quantitative measure of the influence silver nanoparticle size and
concentration has on the 2-octyl cyanoacrylate tissue adhesive.
6.2.2 CFU Counting
The CFU counts supported the results from the Kirby-Bauer disk diffusion
susceptibility test indicating that silver nanoparticles imparted their antibacterial
properties to the tissue adhesive. The original tissue adhesive can only seal and protect
the wound from environmental bacteria and factors. The presence of bacteria from an
improperly cleansed wound will allow bacteria to continue to grow in the wound and
under the sealing adhesive layer. Our results show that tissue adhesives doped with silver
nanoparticles displayed a significant, order of magnitude reduction of bacterial growth
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than undoped tissue adhesives. This decrease in bacterial growth reduces the chance of
bacteria in the wound producing an inflammatory response and possibly leading to
infection. If a wound is currently inflamed or infected, the silver nanoparticle-infused
tissue adhesive can aid in reducing the degree of inflammation or infection by preventing
bacteria from continual growth and reproduction.
The 10-2 dilution of the unaltered adhesive was used for the colony counts
because the 10-1 dilution culturing dishes were confluent with E. coli and colonies were
not distinguishable to be easily counted. In contrast, the culturing dishes containing
silver nanoparticle-infused adhesive samples were counted at 10-1 dilutions due to the
relatively defined outline of the colonies and reasonable count. ImageJ was a reliable
software to count the number of colonies on each culturing dish; however, like with all
software and methods, there were some limitations. The software detected certain
specified parameters that were included in the colony count. The color, size, and
circularity of the colonies were set to the desired specifications. For this research, the
color of the E. coli colonies was set to be detected when adjusting the color threshold.
The size of the colonies was based on choosing the typical smallest colony as the
minimal pixel size and including colonies larger than the smallest colony as part of the
count. Small pixels displayed and detected as the same color as the colonies were
considered artifactual and were excluded from the count. The acceptable circularity was
set to all shapes because E. coli colonies are not consistently circular.
The difference in CFU counts between the composite samples and unaltered
samples was statistically significant with a p-value less than 0.01. Although the silver
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nanoparticle-infused tissue adhesive demonstrated an order of magnitude reduction of
bacterial growth compared to the adhesive alone, the antibacterial effectiveness of the
four combinations of silver nanoparticle concentration and size varied slightly between
each other. A 2-way ANOVA test was performed in Microsoft Excel to determine the
level of effect the silver nanoparticle size and concentration had on the antibacterial
effectiveness and if there was interaction between these two factors. The 2-way ANOVA
test results showed that there was no significant interaction between silver nanoparticle
size and concentration, which means that the response to size was not dependent on the
concentration and vice versa. There was a negligible difference in antibacterial efficacy
of the varying size and concentration combinations. The slight difference in antibacterial
efficacy when varying the nanoparticle size from 4 nm to 10 nm is possibly due to the
relatively small difference in nanoparticle size. A larger difference between nanoparticle
sizes can possibly better distinguish the effects of silver nanoparticle size on antibacterial
effectiveness. The difference in antibacterial efficacy was minimal when silver
nanoparticle concentration was varied for this CFU counting test. This is possibly due to
after reaching certain concentration levels E. coli growth was the same because E. coli
growth has essentially stopped. Increasing the silver nanoparticle concentration after
reaching this concentration threshold level would not further reduce the amount of E. coli
grown, which was also seen in previous research when performing CFU counts [35].
Although the difference between the various doped adhesive combinations was minimal,
the CFU counts showed that a higher concentration of silver nanoparticles within the
adhesive does reduce the number of bacterial colonies grown. When increasing the
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concentration from 1 μg/mL to 10 μg/mL, the average logarithmic CFU count for the 4
nm and 10 nm silver nanoparticles were 3.89 to 3.81 and 3.90 and 3.87, respectively.
Our findings supported previous research that a higher concentration of silver
nanoparticles increases antibacterial efficacy [25]. Furthermore, the average logarithmic
CFU counts depict that the smaller silver nanoparticle size showed a greater antibacterial
effect on bacteria growth than the larger nanoparticle. This supports previous research
that the smaller silver nanoparticle size has a greater antibacterial effectiveness than
larger nanoparticles [35]. The 10 μg/mL of 4 nm silver nanoparticles within the 2-octyl
cyanoacrylate samples possesses both the high concentration and the small nanoparticle
size combination. Our results supported that this combination had the greatest
antibacterial efficacy among all the tested combinations.
6.3

Breaking Load Testing
The infusion of silver nanoparticles into the 2-octyl cyanoacrylate caused the

breaking load force of the adhesive to increase. The average breaking load of the
unaltered adhesive was 0.46 MPa. Increasing the silver nanoparticle concentration in the
adhesive increased the breaking load. The increased concentration of 4 nm nanoparticles
from 1 μg/mL to 10 μg/mL showed about an average 0.32 MPa increase in breaking load,
while the 10 nm nanoparticle concentration increase from 1 μg/mL to 10 μg/mL
demonstrated about an average 0.7 MPa increase in breaking load of the adhesive. The
greatest breaking load was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive.
The increased concentration of nanoparticles resulted in an increase of the adhesive’s
breaking strength, which supported previous research findings that increased mechanical
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strength were due to the dispersion of more nanoparticles to interact with the polymer
matrix [31,59].
Increasing the size of the nanoparticles from 4 nm to 10 nm at 1 μg/mL minimally
increased the breaking load force of the adhesive. The 10 μg/mL of 4 nm and 10 nm
showed about an average 0.39 MPa increase in breaking load of the adhesive. This
difference in average breaking load may be due to the wider range of responses of these
samples. The range of responses for the 1 μg/mL of 4 nm and 10 nm sample
combinations were narrower. The difference between the doped and undoped samples
was statistically significant with a p-value less than 0.01. A 2-way ANOVA test was
executed in Microsoft Excel and found that the silver nanoparticle concentration had a
significant effect on the breaking load results, while there was no significant difference
between the silver nanoparticle sizes on the results. The increase of silver nanoparticle
concentration showed a clearer effect on the mechanical strength of the tissue adhesive,
but the effect of silver nanoparticle size on the adhesive’s mechanical strength was
minimal. The 2-way ANOVA test results also showed that there was no significant
interaction between silver nanoparticle size and concentration, which means that the
response to size was not dependent on the concentration and vice versa.
6.4

Adhesive Force Testing on Porcine Eyes
The adhesive force increased when silver nanoparticles were added to the 2-octyl

cyanoacrylate tissue adhesive. The average adhesive force of the unaltered adhesive was
0.008 MPa. The adhesive force slightly increased to an average of 0.010 MPa when 1
μg/mL of 4 nm silver nanoparticles was infused into the adhesive. Increasing the
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concentration of the silver nanoparticles in the adhesive showed a greater increase of
adhesive strength. The adhesive doped with 10 μg/mL of 10 nm silver nanoparticles
required the most force to fracture the adhesive bonds. On average, the adhesive strength
of the adhesives containing 10 μg/mL of 4 nm nanoparticles and 1 μg/mL of 10 nm
nanoparticles was also greater than the unaltered adhesive and 1 μg/mL of 4 nm
composite adhesive. The increased concentration increased the interaction of the
nanoparticles with the polymer matrix and was expected to enhance the adhesive strength
of the adhesive [31,59].
The adhesive strength of the 1 μg/mL of 10 nm composite adhesive was higher
compared to the 1 μg/mL of 4 nm doped adhesive. This was possibly due to the wider
range of variability in the results for the 1 μg/mL of 10 nm composite adhesive than the 1
μg/mL of 4 nm doped adhesive. The wider range of responses can be attributed to the
uniqueness of each porcine eye and variability between each other. The shape of the test
substrate can be a factor that might affect the bonding of the adhesive. Even though the
flat area of the T-structure was firmly pressed and adhered to the porcine eyeball, the
eyeball might have reverted to its natural spherical shape. Furthermore, the variation in
surface morphology of each sclera can contribute to the broad range of responses. A 2way ANOVA test was performed in Microsoft Excel to determine the effect of silver
nanoparticle concentration and size on the adhesive force and if there was interaction
between these two factors. The 2-way ANOVA test results showed that there was no
significant interaction between silver nanoparticle size and concentration, which means
that the response to size was not dependent on the concentration and vice versa. We
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found that the silver nanoparticle concentration had a significant effect on the adhesive
force results, while there was a negligible difference between the silver nanoparticle sizes
on the results. Because of this 2-way ANOVA test, the results from this experiment
suggest that the increase of nanoparticle concentration in the adhesive resulted in
enhanced adhesive strength. The results from varying nanoparticle sizes were
comparable among each other. The difference between the composite samples and
unaltered samples was statistically significant with a p-value less than 0.05.
An increased adhesive strength indicates that the adhesive holding together two
ends of tissue requires greater force to separate the adhesive bonds. This is particularly
important because the adhesive will prevent the two ends of tissue from further
separation when sudden or excessive force is applied. Although doping the adhesive with
silver nanoparticles increased the mechanical strength when tested on the porcine eyes,
the strength of the adhesive on different tissues in the body can possibly vary because
adhesive strength is highly dependent on the test substrate [38]. Since 2-octyl
cyanoacrylate is already used to treat wounds from many areas of the body including the
eye, the increased adhesive strength of the composite adhesive enhances the performance
of the adhesive while imparting an antibacterial effect.
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CHAPTER SEVEN
CONCLUSION
The infusion of silver nanoparticles into a 2-octyl cyanoacrylate tissue adhesive
does impart an antibacterial effect to the adhesive. The greatest antibacterial effect came
from imbuing 10 μg/mL of 4 nm silver nanoparticles into the tissue adhesive, which was
shown in both the Kirby-Bauer test and CFU counting. There were distinct inhibition
halos surrounding each composite sample, whereas there were no halos surrounding
unaltered samples for the Kirby-Bauer test. A significant, order of magnitude reduction
of bacterial growth was seen from the doped adhesive compared to the unaltered adhesive
when the CFU counting test was performed. While the addition of silver nanoparticles
caused a significant reduction in the number of E. coli colonies for the doped adhesives,
the difference among the varying silver nanoparticle size and concentration combinations
was minimal.
The results of the breaking load test showed the addition of silver nanoparticles
into the adhesive increased the breaking strength of the adhesive. The greatest breaking
load was the 10 μg/mL of 10 nm silver nanoparticle-doped adhesive. The adhesive
strength of the adhesive increased when silver nanoparticles were added and applied to
the incised porcine sclera. The 10 μg/mL of 10 nm silver nanoparticle-infused adhesive
also demonstrated the greatest adhesive strength. The increased adhesive strength
indicates that the adhesive fastening together two ends of tissue requires greater force to
break the adhesive bonds.
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With the definite antibacterial efficacy and increased mechanical strength of this
silver nanoparticle-doped adhesive, this silver nanoparticle-infused 2-octyl cyanoacrylate
tissue adhesive outperforms conventional tissue adhesives. Decreasing bacterial growth
in a wound reduces the chance of infection at the wound site. This also reduces other
complications associated with infection and minimizes healing time. Patients will
experience less discomfort around the wound compared to mechanical fasteners such as
sutures or staples. Furthermore, tissue adhesives are more suitable for delicate tissues
such as the eye, because it is less traumatic to the tissue than rigid fasteners. Ultimately,
the silver nanoparticle-infused tissue adhesive investigated in this research can be an
alternative or supplement to mechanical fasteners, which allows doctors the option to
select whatever tissue binding method is most appropriate for the situation.
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CHAPTER EIGHT
FUTURE WORK
Despite the noticeable antibacterial effect of the silver nanoparticle-infused tissue
adhesive over the unaltered adhesive, there were small differences between the varying
silver nanoparticle size and concentration combination in terms of antibacterial efficacy.
Though the results suggest the 10 μg/mL of 4 nm silver nanoparticles within the 2-octyl
cyanoacrylate possesses a greater bactericidal effect, the antibacterial efficacy was
marginally better than the other factor combinations. Future research can be conducted to
determine if larger size silver nanoparticles in the adhesive continue to affect antibacterial
efficacy positively or negatively.
Future research can also be performed to determine the effect of larger size silver
nanoparticles on the mechanical strength of the adhesive. Further testing can involve
examining what silver nanoparticle size and concentration will provide the optimal
antibacterial and mechanical adhesive composition. There are many other characteristics
of this tissue adhesive that can be tested to further understand its properties and its effect
on other tissue. This tissue adhesive can be developed to be safe for in vivo use upon the
completion of additional in-depth research.
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APPENDIX A
DISTANCES BETWEEN SILVER NANOPARTICLES
Label
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Length (nm)
28.01
36.59
28.48
40.16
14.22
41.36
35.67
37.27
30.70
37.82
38.36
48.24
33.07
36.53
58.18
47.95
37.82
36.25
19.37
8.40
40.03
32.90
36.02
37.82
38.01
23.88
50.17
50.75
40.02

Label
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58

Length (nm)
28.48
33.07
40.57
32.66
62.59
69.79
58.55
27.53
45.39
51.03
50.38
11.41
17.13
44.71
43.91
8.70
61.40
19.64
47.53
17.93
60.68
74.46
51.56
57.91
44.09
25.68
20.25
35.98
25.47

Label
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87

101

Length (nm)
36.96
26.09
31.77
34.02
18.88
15.92
12.64
33.87
40.42
46.38
43.74
25.06
16.09
41.74
39.16
38.19
42.79
52.26
45.23
40.75
63.95
40.88
59.49
41.36
62.07
49.33
23.51
29.74
18.99

Label
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111

Length (nm)
26.66
47.52
16.65
50.59
44.31
47.05
43.93
27.17
41.20
35.83
7.94
18.34
46.79
50.53
48.45
18.36
20.02
21.17
15.75
37.28
26.01
39.69
51.90
62.34

Mean
SD
Min
Max

37.20
14.41
7.94
74.46

APPENDIX B
KIRBY-BAUER DISK DIFFUSION SUSCEPTIBILITY TEST
Name

Adhesive Alone

1 μg/mL, 4 nm
AgNP + Adhesive

10 μg/mL, 4 nm
AgNP + Adhesive

1 μg/mL, 10 nm
AgNP + Adhesive

10 μg/mL, 10 nm
AgNP + Adhesive

Inhibition Halo
Diameter (mm)
0
0
0
0
0
10
11
11
12
11
14
15
17
17
13
11
12
13
13
12
13
12
11
12
12

Average (mm)

Standard
Deviation

p -value

0

0

N/A

11

0.71

2.55E-10

15.2

1.79

3.05E-08

12.2

0.84

4.27E-10

12

0.71

1.28E-10
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APPENDIX C
CFU COUNTS
Name

Adhesive Alone

1 μg/mL, 4 nm
AgNP + Adhesive

10 μg/mL, 4 nm
AgNP + Adhesive

1 μg/mL, 10 nm
AgNP + Adhesive

10 μg/mL, 10 nm
AgNP + Adhesive

Colonies

Dilution
Concentration

Log

610
587
554
1225
995
760
680
520
1176
903
830
570
410
679
872
860
720
690
610
1200
463
640
960
1158
654

61000
58700
55400
122500
99500
7600
6800
5200
11760
9030
8300
5700
4100
6790
8720
8600
7200
6900
6100
12000
4630
6400
9600
11580
6540

4.79
4.77
4.74
5.09
5.00
3.88
3.83
3.72
4.07
3.96
3.92
3.76
3.61
3.83
3.94
3.93
3.86
3.84
3.79
4.08
3.67
3.81
3.98
4.06
3.82
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Average

Standard
Deviation

p -value
(Logarithmic)

4.88

0.16

N/A

3.89

0.13

2.44E-06

3.81

0.13

1.38E-06

3.90

0.11

1.67E-06

3.87

0.16

3.66E-06

APPENDIX D
BREAKING LOAD TESTING
Name

Adhesive Alone

1 μg/mL, 4 nm
AgNP + Adhesive

10 μg/mL, 4 nm
AgNP + Adhesive

1 μg/mL, 10 nm
AgNP + Adhesive

10 μg/mL, 10 nm
AgNP + Adhesive

Breaking Load
(MPa)
0.59
0.50
0.44
0.36
0.42
0.77
0.89
0.66
0.75
0.69
0.84
0.85
1.15
1.54
0.98
0.78
1.07
0.71
0.59
0.64
1.56
1.70
1.26
0.99
1.79

Average (MPa)

Standard
Deviation

p -value

0.46

0.09

N/A

0.75

0.09

4.47E-04

1.07

0.29

9.89E-04

0.76

0.19

6.68E-03

1.46

0.33

9.46E-05
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APPENDIX E
ADHESIVE FORCE TESTING
Name

Adhesive Alone

1 μg/mL, 4 nm
AgNP + Adhesive

10 μg/mL, 4 nm
AgNP + Adhesive

1 μg/mL, 10 nm
AgNP + Adhesive

10 μg/mL, 10 nm
AgNP + Adhesive

Adhesive Force
(MPa)
0.012
0.009
0.007
0.007
0.006
0.011
0.009
0.010
0.009
0.012
0.014
0.021
0.024
0.031
0.026
0.019
0.024
0.016
0.016
0.014
0.022
0.018
0.021
0.029
0.035

Average (MPa)

Standard
Deviation

p -value

0.008

0.002

N/A

0.010

0.001

4.46E-02

0.023

0.006

4.92E-04

0.018

0.004

7.82E-04

0.025

0.007

4.37E-04
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